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Introduction: Self-management plays a central role in the treatment chronic obstructive 
pulmonary disease (COPD). However, the patient characteristics necessary for effective self-
management are not understood. The skills, confidence, and knowledge to engage in chronic 
disease self-care, known as patient activation, may play a key role in the capacity of people to 
self-manage COPD. How the complex, systemic nature of COPD influences patient activation 
has not been explored. Therefore, the purpose of this study was to examine the relationships 
among patient characteristics and health outcomes as determinants of patient activation among 
community-dwelling adults in the U.S. with COPD. The Revised Wilson Cleary Model (Ferrans, 
Zerwic, Wilbur & Larson, 2005) was adapted to examine a continuum of integrated variables 
integral to the experience of COPD for this descriptive correlational survey study. 
Methods: A random sample of 64 community-dwelling adults with COPD completed a self-
report postal survey. The questionnaire was comprised of demographic questions and the 
Positive Affect Negative Affect Schedule, to measure individual and environmental patient 
characteristics, and the Quality of Life Index Pulmonary Version III, Pulmonary Functional 
Status and Dyspnea Questionnaire-Modified, a single question to assess general perception of 
health, and the Patient Activation Measure-13 (PAM) to assess health outcomes. Additionally, 
spirometry data was abstracted from participants’ medical records. Descriptive and univariate 
statistics were utilized to describe and examine the unadjusted associations between patient 





associated with patient activation were entered into stepwise multivariate regression models to 
identify independent predictors of patient activation in the sample. 
Results: The participants in the study were mostly men and women in their 70s with moderate to 
severe COPD, having lived with the disease for over four years. The patient activation scores 
were high among the sample (M = 66, SD = 16), with over 70% of the sample activated at PAM 
Level 3 and 4 (n = 47, 73%). Univariate analyses revealed significant relationships between 
several patient characteristics (gender, positive affect, lower Body Mass Index, education level, 
time since diagnosis of COPD, smoking pack years, urban residence) and patient activation. 
Health outcome domains, such as low fatigue, good or very good general perception of health, 
and better perceived overall quality of life) were directly related to patient activation in the 
sample. The resulting statistically significant regression model (R2 = .488, Adj.R2 = .454, p < 
.001) contained four independent predictors explaining 45% of the variation in patient activation 
in the sample. Positive affect β = .457 contributed most to the model, followed by smoking pack 
years β = .345, overall quality of life β = .264, and female gender β = -.192.  
Conclusions: Several patient characteristics and complex health outcomes underlie self-
management capacity in COPD. This study revealed novel determinants of patient activation that 
have implications for COPD self-management science and nursing practice. Nurses are in a 
pivotal position to apply knowledge of patient activation to the individualized assessment and 
care interventions of people living with COPD. Further research is needed to explicate the 
unique psychosocial factors that contribute to capacity to self-manage for targeted intervention 








More than 15 million Americans have chronic obstructive pulmonary disease (COPD), 
the fourth leading cause of chronic morbidity and preventable death in the United States (CDC, 
2017). COPD is defined as “a preventable and treatable disease state characterized by airflow 
limitation that is not fully reversible…the airflow limitation is usually progressive and associated 
with a chronic inflammatory response of the lungs to noxious particles or gases” (Celli et al., 
2015, p. e5). Often referred to as an umbrella diagnosis, COPD encompasses a spectrum of 
chronic lung diseases, including chronic bronchitis and emphysema (GOLD, 2018). These 
diseases are thought to be caused by long-term exposure to airway irritants, most commonly 
cigarette smoking, and are characterized by air flow obstruction causing debilitating shortness of 
breath, coughing, and fatigue (ALA, 2017; CDC, 2017). Exacerbations and development of 
comorbid conditions are typical in the progression of COPD and contribute to overall disease 
severity and mortality (Halding and Grov, 2017). The incidence of COPD is roughly equal 
between the genders, though in the last decade women exceed men in the numbers of both newly 
diagnosed and those dying from the condition (ALA, 2017; Celli et al., 2015; Pruitt, 2014).  
 COPD treatment plans are multifaceted with self-management intensive (Titova et al., 
2017; Disler, Gallagher & Davidson, 2012). The plans require patients to monitor and manage 





regimens, engage in regular physical activity, and actively maintain supportive relationships 
(Celli et al., 2015; Disler et al., 2012; Kaptein, Fischer & Scharloo, 2014). As COPD cannot be 
cured, the goals of treatment are to slow disease progression, and maintain function and quality 
of life (Kruis et al., 2013). 
Research Problem  
 Evidence suggests vigilant self-management is directly associated with reduced hospital 
admissions, decreased perception of shortness of breath, and improved quality of life in people 
with COPD (Andenaes, Bentsen, Hvinden, Fagermoen & Lerdal 2014; Zwerink et al., 2014). 
Studies have also shown that less than one-half of patients with COPD demonstrate adherence to 
recommended self-management activities prescribed in their treatment plans (Bischoff et al., 
2012; Bucknall et al., 2012). Further, randomized clinical trials investigating approaches to 
effectively teach and support patients with COPD to self-manage have yielded controversial 
results, including adverse events (Kaptein et al., 2014; Nici, Bontly, ZuWallack & Gross, 2014).  
 Though the burden of COPD has been implicated with poor adherence to treatment 
plans, it is highly debated in the field why self-management interventions succeed for some 
patients and fail for others (Bender, 2014; Titova et al., 2017). To address the disparate results of 
intervention trials and low treatment adherence among adults with COPD, the research 
community have begun to question what patient characteristics are necessary to become 
motivated and effectively engage in self-management behaviors (Nici et al., 2014). As clinicians 
and researchers call for individualized approaches to care tailored to the unique characteristics 
and strengths of individuals with COPD, knowledge of these factors is needed. 
 The patient’s capability to self-manage this chronic disease has gained the attention of 





self-management processes (Moore et al., 2016) and a reliable measure of self-management 
capacity in chronic disease (Hibbard, Greene, Shi, Mittler & Scanlon, 2015). Patient activation 
reflects individual’s beliefs that they have an important role to play in their health and is 
demonstrated through the knowledge, skills, and confidence to maintain function, respond to 
changes in health, and access appropriate care for their health needs (Hibbard, Stockard, 
Mahoney & Tusler, 2004). The Patient Activation Measure (PAM) objectively characterizes an 
individual’s activation level on a developmental spectrum of the passive care receiver with 
limited self-management capacity (Level 1) to the confident, capable, and engaged self-manager 
(Level 4) (Hibbard et al., 2004). The higher the level of patient activation an individual has, the 
more likely he or she will have a sense of responsibility for their health, carry out self-care 
activities to maintain wellness, engage with the health care system, and achieve treatment goals, 
(Dixon, Hibbard & Tusler, 2009; Greene, Hibbard, Sacks, Overton & Parrotta, 2015; Mosen et 
al., 2007).  
 Despite the growing body of evidence that suggests patient activation is the most 
reliable indicator of a patient’s ability to manage his or her chronic disease (Coventry, Fisher, 
Kenning, Been & Bower, 2014; Green et al., 2015; Halding & Grov, 2017), determinants and 
mediators of patient activation are still relatively unknown (Hibbard et al., 2015). Understanding 
the impact of chronic disease and healthcare practices on patient activation level has recently 
emerged as a focus of nursing inquiry. Several studies have attempted to identify determinants of 
patient activation in adults with a variety of chronic diseases. The results of these studies are 
broad and contrasting, preventing any consensus of the factors that may predict patient activation 
(Graffigna, Barello & Bonanomi, 2017). Further, most were conducted without a theoretical or 





application in clinical practice (Bos-Touwen et al., 2015; Hibbard et al., 2015; Korpershoek et 
al., 2016).  
 The concept of patient activation has relevance in the treatment of COPD where the 
onus of treatment success lies in the capacity of the patient to engage in treatment plans is 
dependent upon self-management behaviors. Knowledge about how the complex, systemic 
nature of COPD affects patient activation development is lacking in the literature (Evans & 
Morgan, 2014; Korpershoek, 2015; Titova et al., 2017). In addition, the underlying patient 
characteristics supporting patient activation in the individual with COPD have not been 
explicated (Case et al., 2017). Nurses are pivotal in delivery of self-management education and 
support to people with COPD, thus knowledge of ways to promote patient activation is important 
to nursing practice. Examining how individual patient and disease-specific factors affect patient 
activation level, through the lens of an organizing conceptual framework, would inform a gap in 
the patient activation and COPD self-management evidence bases.  
 Evidence of patient activation as a predictor of chronic disease outcomes carries health 
policy implications for COPD care. Health care utilization rates and costs for people with a 
primary diagnosis of COPD are approximately twice that of age and sex-matched controls 
(Green et al., 2015). Preventing readmission to the hospital through self-management is a 
national priority for COPD care, as one in five people hospitalized for an exacerbation of COPD 
will require re-hospitalization within 30 days (Charlot et al., 2017; National Quality Measures 
Clearinghouse, 2017). Patient activation has been shown to mediate collaborative self-
management programming and hospitalization rates in people with COPD, thus, patient 
activation may be a modifiable target in practice and policy planning efforts to reduce 





evidence shows adults with higher patient activation levels are more likely to participate in 
symptom monitoring and medication adherence (Hibbard & Greene, 2013, 2014; Hibbard et al., 
2015), two key self-management behaviors strongly associated with decreased hospitalization 
and re-hospitalization for acute exacerbation of COPD (Roberts et al., 2016; Zwerink et al., 
2014). Because COPD is a resource-intensive disease process imparting costly healthcare 
utilization burden on patients, providers, and payers (Dhamane et al., 2015), an examination of 
the influencing factors for patient activation in this population is warranted.  
Conceptual Framework 
 Patient activation is a multidimensional concept yet to be examined or tested within a 
conceptual or theoretical framework. Therefore, a robust conceptual model that examines patient 
activation in the bio-behavioral context of COPD is needed to guide this study. The widely used 
Revised Wilson Cleary Model of Health-Related Quality of Life (Ferrans, Zerwic, Wilbur & 
Larson, 2005) was chosen to guide the description and examination of relationships among 
patient characteristics, health outcomes, and patient activation among adults with COPD.   
 In 1995 Wilson and Cleary (1995) proposed a model to help clinicians and researchers 
conceptualize and test potential relationships among health outcomes and their collective impact 
on overall quality of life in the setting of chronic disease. The Wilson Cleary Model of Health-
related Quality of Life (Wilson & Cleary, 1995) integrated the biomedical and sociological 
scientific views of quality of life and proposed taxonomy of health outcome measures organized 
by dominant causal relationships. Five outcome levels of health in chronic disease were proposed 
in the model: (a) biological/physiological variables, (b) symptoms status, (c) functional status, 
(d) general health perceptions, and (e) overall quality of life (Wilson & Cleary, 1995). The 





other, and may be influenced by the individual and environmental characteristics of the person 
living with a chronic disease (Wilson & Cleary, 1995).  
In 2005 Ferrans, Zerwic, Wilbur, and Larson revised the Wilson Cleary Model (Wilson & 
Cleary, 1995) to explicate the conceptual definitions of individual and environmental 
characteristics and theoretically ground their relationships with each of the five health outcome 
levels of the model. Ferrans et al. (2005) asserted that the characteristics of individuals and their 
environment were significant and influenced all the health outcomes within the model. See 
Figure 1. In addition, the authors expanded the definitions of each of the health outcome levels, 
providing real-life examples of the outcomes and their relationships with other factors in the 
model in the context of nursing care situations. Their primary goal of the revision was to increase 
utility of this comprehensive health outcome model for guiding nursing research in chronic 
disease (Ferrans et al., 2005). Both versions of the model have been widely utilized in COPD 
health outcomes research, including examinations of general perceptions of health and overall 






Figure 1. The Revised Wilson Cleary Model of Health-related Quality of Life. Adapted from 
“Conceptual model of health‐related quality of life,” by C.E. Ferrans, J. Zerwic, J. Wilbur, and J. 
Larson, 2005, Journal of Nursing Scholarship, 37(4), 336-342. Copyright by C.E. Ferrans. 
 
 The Revised Wilson Cleary Model of Overall Quality of Life (Ferrans et al., 2005) 
organizes categories of health outcomes in chronic disease on a continuum of increasing 
complexity and integration. Though dominant causal associations between individual and 
environmental characteristics and the continuum of health outcomes are proposed, reciprocal, 
mediated, or integrated relationships may exist (Ferrans et al., 2005). Consistent with Wilson and 
Cleary (1995), Ferrans et al. (2005) assert that the model is intended to be fluid enough for 
guiding health outcomes inquiry as well as testing relationships among the concepts described in 
the model domains.  
 The Revised Wilson Cleary Model (Ferrans et al., 2005) afforded a fitting frame to 
examine potential relationships among patient characteristics, COPD-specific health outcomes, 
and patient activation. Patient activation and overall quality of life are modifiable, subjective, 
and fluid health outcomes shaped by life circumstances and health status (Ferrans, 1996; Ferrans 
et al., 2005; Guyatt, Feeny & Patrick, 1993; Hibbard & Green, 2013; Wilson & Cleary, 1995). 
Both concepts have been identified as causal influences, mediators, and predictors of health 
behaviors and patient outcomes in COPD (Guyatt et al., 2007; Hibbard et al., 2015; Kaptein et 
al., 2014). The levels of patient activation reflect a continuum of developmental capacity to 
apply necessary knowledge, skill, and confidence to self-manage one’s health in the setting of 
chronic disease (Hibbard & Mahoney, 2010). This is consistent with Wilson and Cleary’s view 
that measures of health can be categorized as existing on a continuum of increasing biophysical, 





 This study adapts the Revised Wilson Cleary Model (Ferrans et al., 2005) to include 
patient activation adjacent to overall quality of life on the far right of the model. Wilson and 
Cleary (1995) originally depicted quality of life as an end-point in the model because of the 
integrative complexity of the concept. Patient activation shares similar integrated 
biopsychosocial complexity (Hibbard & Mahoney, 2010). Based on the congruency of these 
conceptual descriptions, patient activation was purposefully integrated as an end point in the 
model. Figure 2 illustrates the theoretical continuum and adaptation of the model.  
 
Figure 2. Revised Wilson Cleary Model of Health-relate Quality of Life Adapted to Include 
Patient Activation. Adapted from “Conceptual model of health‐related quality of life,” by C.E. 
Ferrans, J. Zerwic, J. Wilbur, and J. Larson, 2005, Journal of Nursing Scholarship, 37(4), 336-
342. Copyright by C.E. Ferrans. Model adapted with permission from C.E. Ferrans. 
 
 An additional adaptation of the model was a change in the visual representation of the 
relationships among the health outcome domains. The model provided a framework for 
examination and description of relationships among relevant individual, environmental, and 
health outcome factors and patient activation, not testing of the model for fit. Thus, the 





unidirectional flow of health outcomes toward the end points of overall quality of life and patient 
activation. Unlike the original model, the lines were depicted in a dotted format, representing a 
tentative relationship, to be explored in the aims of this study. The visual change is congruent 
with Ferrans et al. (2005) and Wilson and Cleary (1995), whose research reveals it is conceivable 
and probable that any arrow between the health outcomes could point in an opposite direction or 
both directions, reflecting the complexity of interactions between and among them.  
Purpose Statement 
 The purpose of this study was to describe and examine the relationships among patient 
characteristics and health outcome factors, as conceptualized in the Revised Wilson Cleary 
Model (Ferrans et al., 2005) as determinants of patient activation in adults with COPD. 
Specific Aims and Research Questions 
 The specific aims and research questions that guided this cross-sectional, quantitative 
study include:  
1. Describe the patient characteristics (individual and environmental), health outcome factors 
(biological function, symptoms, functional status, general perception of health, and overall 
quality of life), and patient activation experienced by a cross-sectional sample of adults in the 
United States with COPD. 
Q1. What are the patient characteristics of the sample? 
Q2. What are the health outcome factors experienced by the sample?  
Q3. What is the patient activation level of the sample? 
2. Examine the unadjusted associations that patient characteristics and health outcome factors 





Q4. What are the presence, strength, and direction of the relationships among the patient 
characteristics, health outcome factors, and patient activation level in the sample? 
3. Identify the independent predictors of patient activation in the sample. 
Q5. Which patient characteristics and/or health outcome factors explain the greatest 
percentage of the variance in patient activation within the sample? 
Definition of Terms 
Several key terms were presented in the research questions underpinning this study.  
COPD, patient activation, and the domains presented within the Revised Wilson Cleary Model 
(Ferrans et al., 2005) are conceptually defined in Table 1 to provide clarity of intent within the 
context of this study. Objective measures and empirical tools, congruent conceptually and 
operationally with of each of the study variables, are described in greater detail in Chapter III.  
Table 1. Definition of Terms. 
Term Definition 
Adults with COPD People with a clinical diagnosis of COPD, chronic bronchitis, or 
emphysema. Though chronic asthma of adulthood, bronchiectasis, and 
alpha-1 antitrypsin deficiency are also included under the umbrella of 
COPD (GOLD, 2018), for the purposes of this study only the initial 
three diagnoses were included. 
 
Biological function The molecular, cellular, and whole organ system processes that support 
life (Ferrans et al., 2005). Operationally, biological function is defined 
as the measures used to assess and diagnose organ function (Wilson & 
Cleary, 1995). For this study, severity of COPD quantified by 
spirometric measure of lung function (forced expiratory volume in one 




The social or physical factors influencing health of the individual 
within their living setting (Ferrans et al., 2005). Friends, family, and 
caregivers represent the interpersonal and social influences of health 
within one’s environment. The setting in which one lives, works, and 
engages socially also influences health outcomes (Ferrans et al., 2005). 





category of residence (rural or urban), (b) marital status (single, 
married/committed relationship, separated/divorced, or widowed), and 




The demographic, psychological, developmental, and biological factors 
that collectively influence health outcomes (Ferrans et al., 2005). For 
this study, the characteristics of the individual were determined 
through self-report of the following variables: (a) demographic 
measures (age, gender, race, ethnicity, formal education, earned 
income level, working status), (b) psychological measures (positive 
and negative affect as measured by the Positive Affect Negative Affect 
Schedule), and (c) biological measures (height and weight to calculate 
Body Mass Index).  
 
Determinants Influencing factors that decisively affect the nature or experience of a 
health outcome in chronic disease (Dictionary.com, 2016). 
Operationally, a determinant reflected an independent variable 
reflecting a significant relationship with the dependent variable through 
multivariate regression statistical analysis. 
 
Dyspnea The perception of labored, uncomfortable breathing (Tel, Bilgic & 
Zorlu, 2012). Dyspnea is a medical term synonymous with shortness of 
breath. 
 
Fatigue A multidimensional sensation of tiredness perceived as deterring one’s 
capacity to function normally in the setting of COPD (Kapella, Larson, 
Patel, Covey & Berry, 2006).  
 
Functional status A person’s ability to perform tasks in multiple domains reflecting 
adequate physical, social, role and emotional capacity (Ferrans et al., 
2005). Functional status is operationalized as the total score of the 
Pulmonary Functional Status and Dyspnea Questionnaire-Modified 




A person’s subjective perception of overall health status (Ferrans et al., 
2005). Wilson and Cleary (1995) asserted that self-rated health was 
synonymous with general health perception, thus the single question 
from the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992) 
asking, “How would you rate your health? Excellent, very good, good, 
fair, or poor?” was utilized to operationalize this health outcome. 
 
Health outcomes Umbrella term referring to all patient health outcome levels (Ferrans et 
al., 2005) or domains (Wilson & Cleary, 1995) presented in the 
Revised Wilson Cleary Model of Overall Quality of Life and the 





this study, health outcomes include biological function, symptoms, 
functional status, general health perception, and overall quality of life, 
as named by Ferrans et al. (2005). 
 
Overall quality of 
life 
The subjective, multidimensional measure of well being and 
satisfaction of one’s life with chronic disease (Ferrans et al., 2005).  
For this study overall quality of life was operationalized by the total 
score from the Quality of Life Index Pulmonary Version III (Ferrans & 
Powers, 1985). 
 
Patient activation An individual’s belief she or he has an important role to play in their 
health, demonstrated through the knowledge, skills, and confidence to 
maintain function, respond to health changes, and access appropriate 
care for their health needs (Hibbard, et al., 2004). Patient activation 
was operationalized by the Patient Activation Measure-13 (Hibbard, 




Umbrella term referring to both the characteristics of the individual and 
characteristics of the environment, as presented in the Revised Wilson 
Cleary Model of Overall Quality of Life (Ferrans et al., 2005) and the 
original Wilson and Cleary Model of Health-related Quality of Life 
(Wilson &Cleary, 1995). 
 
Self-management The medical, emotional, and role management tasks or behaviors to 
manage health and maintain wellness in the setting of chronic disease 
(Grady & Gough, 2014; Lorig & Holman, 2003). 
 
Symptoms Person’s perception of an abnormal physical, emotional, or cognitive 
state (Ferrans et al., 2005). Dyspnea and fatigue are the key physical 
symptoms relevant to COPD. Dyspnea was operationalized by the 
Dyspnea component subscale from the Pulmonary Functional Status 
and Dyspnea Questionnaire-Modified (Lareau, Meek & Roos, 1998). 
Fatigue was operationalized by the Fatigue component subscale from 
the Pulmonary Functional Status and Dyspnea Questionnaire-Modified 




Within chronic disease and self-management science, patient activation has emerged as 
an integral concept in providing patient-centered, individualized care (Bos-Touwen et al., 2015). 





patient activation of adults living with COPD in the United States. The identified determinants of 
patient activation from this study will: (a) inform the nursing care of adults with COPD, (b) 
expand the knowledge of patient characteristics associated with capacity to engage in necessary 
self-management behaviors central to COPD care outcomes, and (c) contribute objective targets 
to apply toward novel intervention design for future COPD self-management research. 
The use of theory to guide research has been a long-standing tradition in the advancement 
of nursing science (Alligood, 2011). Existing conceptual frameworks from nursing, social 
sciences, or medicine may provide guidance for the exploration and interpretation of emerging 
health concepts impacting health and wellbeing (Tappen, 2016). In this study, a widely used bio-
behavioral model from the social sciences was used to examine a new health outcome concept 
originally explicated by health economists, with significant relevance to nursing science. Thus, 
this study demonstrates the importance of sharing among scientific disciplines to expand health 
knowledge (Waltz, Strickland, & Lenz, 2010). The application of a conceptual model of patient 
outcomes in chronic disease organized the study of predominant health, individual, and 
environmental factors, influencing patient activation in this population.  
Nurse scientists have been early adopters of patient activation as both a predictor and 
core outcome measure in chronic disease and self-management research (Hibbard et al., 2015; 
Moore et al., 2016). Patient activation is a complex, yet modifiable, health behavior that directly 
reflects self-management efficacy and capacity (Hibbard & Mahoney, 2010). Thus, the 
determinants that influence patient activation development must be understood just as clearly as 
the self-management outcomes the concept predicts. Therefore, this study contributes to the 





complex health behaviors that underlie self-management efficacy in chronic illness (Grady & 
Gough, 2014).  
The findings from this study have important implications for nursing practice, research, 
education, and policy. First, for nurses in direct care roles, understanding what patient activation 
is and how disease and personal factors influence it will have meaningful impact on the 
assessment, care planning, and educational resources provided to patients and families affected 
by COPD. Knowledge of the personal and health factors associated with low activation will help 
nurses to identify those patients at greatest risk for limited self-management capacity and engage 
them in appropriate care coordination services (Hibbard & Greene, 2013; Naylor, Hirschman, 
O’Connor, Barg & Pauly, 2013). Second, identification of the determinants of patient activation 
addresses a gap in knowledge related to patient characteristics necessary for self-management. 
This research has the potential to advance self-management science research in COPD. Third, 
understanding the relationships among health outcome factors and patient activation will 
enhance academic nursing education relative to chronic disease and self-management. Fourth, 
this study further supports current health policy effort focused on patient engagement in self-care 
when diagnosed with COPD to decrease the demand for health care resources by this high 
healthcare utilization group (Evans & Morgan, 2014; Hibbard, Greene, Sacks, Overton & 
Parrotta, 2016). 
Delimitations  
 The following delimitations provided the boundaries in which this study was conducted.  
• The domains of the Revised Wilson Cleary Model (Ferrans et al., 2005) framed the 
selection of variables to examine as potential determinants of patient activation level in 





identified from the empirical self-management literature examining people living with 
from COPD, and published examinations of determinants of patient activation.   
• Patient activation has been linked to and overlapped conceptually with other behavioral 
characteristics in the literature, such as self-efficacy, patient empowerment, and patient 
engagement (Fumagalli, Radaelli, Littieri, Bertele & Masella, 2015). For this study, the 
conceptual definition and singular tool to assess the concept developed by Hibbard, 
Stockard et al. (2004) and Hibbard, Mahoney et al. (2005) was used to define the scope 
of meaning. See Table 1 Definition of Terms in this chapter and Measurement Tools in 
Chapter III. 
• This study includes adults who were diagnosed with COPD, chronic bronchitis, and/or 
emphysema. Adults with chronic asthma, bronchiectasis, and alpha 1 anti-trypsin 
deficiency were not included in the sample, as the causes, trajectory, and treatment plans 
of these obstructive, chronic lung diseases differ from those of chronic bronchitis and 
emphysema (GOLD, 2018). Chronic bronchitis and emphysema constitute the majority 
of COPD diagnoses in the United States (CDC, 2017). 
• To achieve a sample reflective of people with COPD in the United States, the study 
sample was drawn from the electronic medical records of a large, national healthcare 
organization.   
• Because of the nature of the survey study design, the ability to write and read the English 
language was required for participation. 
• As most people were at least 40 years of age when breathing symptoms associated with 
COPD emerged (ALA, 2017), the age of 40 years established the lower threshold for 





study. COPD is a chronic, incurable pulmonary condition; thus, people will live with the 
disease for the remainder of their lives.  
• The comprehensive survey tool provided to study participants was comprised of 
demographic questions and validated, health outcome measures with high reliability in 
the COPD population. Further detail of the survey tool is provided in Measurement 
within Chapter III. 
• Data was included for analysis from completed survey tools returned from study 
participants who provided informed consent. 
• The Dillman Total Design Method (Dillman, Smyth & Christian, 2014) of survey 
research provided the procedure for participant recruitment, survey distribution, and data 
collection. Data collection took eight weeks from the time of initial study mailing to 
completion of survey collection. The procedure and methodology of this approach is 
described in Chapter III. 
Assumptions 
 Assumptions from the extant theoretical and research literature underpinned the 
methods used in this study. First, quality of life and patient activation are complex, 
multidimensional health constructs that are impacted by health status and unique life 
circumstances. Second, unobservable health outcome constructs, such as patient activation, 
functional status, and quality of life, can be objectively measured and understood through use of 
survey tools and statistical analysis. Finally, study participants were truthful in their self-reported 
responses to the questions posed in the study survey tool, which comprised the primary data 





Organization of Remaining Dissertation Chapters 
 The study is organized into five chapters and associated appendices and references. 
Chapter I presents an introduction to the research problem, study purpose, research questions 
guided by a conceptual framework, and the significance of this work to the field of nursing. 
Chapter II provides a comprehensive review of the theoretical and empirical research literature 
related to self-management of COPD and patient activation. Chapter III offers a detailed 
description of the study design and methodology implemented for this study along with a 
description of the statistical analysis to be conducted. The analysis of the data is detailed in 
Chapter IV. Finally, Chapter V provides a discussion of the results, conclusions, and 
recommendations for nursing practice, education, and research. 
Summary 
 Patient activation is an emerging construct predictive of health outcomes in chronic 
disease (Hibbard & Green, 2014). The personal characteristics and health outcomes that 
influence the development and maintenance of patient activation in the setting of chronic disease, 
and specifically COPD, are minimally understood. Adequate patient activation is vital for an 
individual to self-manage (Hibbard et al., 2015), thus understanding patient activation 
determinants is imperative for optimal planning and implementation of self-management 
interventions for people living with chronic disease (Grady & Gough, 2014). Knowledge gained 
from this quantitative study may expand the limited scientific knowledge of determinants of 
patient activation in people living with COPD in the United States. Furthermore, this knowledge 
may directly contribute to clinical care of people with COPD through informed and 







REVIEW OF LITERATURE 
This chapter presents a review of the literature describing the state of the science of self-
management in chronic obstructive pulmonary disease (COPD) and patient activation. The 
review discusses previous research relative to the significance of patient activation on self-
management and health outcomes in chronic disease. Additionally, associations among known 
factors influencing outcomes in COPD and patient activation are identified and organized within 
the domains of the guiding conceptual model. Lastly, gaps in the empirical and theoretical 
literature are presented with discussion of how this study was designed to address them. 
As introduced in the previous chapter, the objective of this study is to describe and 
examine the relationships among patient characteristics and health outcome factors, as 
conceptualized in the Revised Wilson Cleary Model (Ferrans et al., 2005), and to identify the 
determinants of patient activation among adults living with COPD. The specific aims of this 
descriptive correlational study are to: 
1. Describe the patient characteristics (individual and environmental), health outcome 
factors (biological function, symptoms, functional status, general perception of health, 
and overall quality of life), and patient activation experienced by a cross-sectional sample 
of adults with COPD living in the United States. 
2. Examine the unadjusted associations that patient characteristics and health outcome 





3. Identify the independent predictors of patient activation in the sample. 
Search Process 
 The literature reviewed was identified through several databases, including Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, ProQuest, PubMed, 
PsycINFO, and Scopus. Key search terms included chronic obstructive pulmonary disease (or 
chronic lung disease), self-care (or self-management), symptoms, functional status, general 
perception of health, health-related quality of life, and patient-reported outcomes. The search 
timeframe was limited to 2006-2016, though earlier landmark works related to self-management 
were included.  
 Key terms to identify literature-examining determinants of patient activation included 
patient activation (or Patient Activation Measure), determinants, correlates, and predictors. The 
terms were also combined with chronic disease and chronic obstructive pulmonary disease. 
Papers were included if the mean age of the study sample was 40 years of age or older, 
congruent with the typical age in which symptoms of COPD were present and diagnoses were 
made (ALA, 2017), and the identified sample had at least one or more chronic diseases. The 
literature search was framed between 2004-2018, to include the seminal paper introducing the 
Patient Activation Measure (PAM) by Hibbard et al. (2004). Patient activation is frequently used 
interchangeably in the literature with other terms, such as patient engagement and self-
management capacity (Fumagalli et al., 2015), so care was taken to include only literature that 
provided a definition of patient activation consistent with that of Hibbard et al. (2004). 
Chronic Obstructive Pulmonary Disease 
 Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with no 





utilization (Celli et al., 2015), COPD causes considerable mortality as the third leading cause of 
preventable death in the United States (ALA, 2017; CDC, 2017). The goals of COPD treatment 
are to slow lung function decline, limit symptom impact, prevent exacerbations, improve 
exercise tolerance, maintain function, and improve overall quality of life (Qaseem et al., 2011). 
Treatment of COPD consists largely of medications and behavior change support (GOLD, 2018). 
Multiagent medication regimens are prescribed based on the individual’s symptom profile, 
exacerbation history, and severity of airway obstruction (Balkissoon, Lommatzsch, Carolan & 
Make, 2011; Mannino et al, 2014). Lifestyle and behavior changes target maintaining pulmonary 
function and limiting disease progression through avoidance of airway irritants (primarily 
smoking cessation), prompt response to symptom change and physical activity (GOLD, 2018; 
Rice, Bourbeau, MacDonald & Wilt, 2014). Primary care providers, pulmonologists, and 
pulmonary rehabilitation providers direct COPD treatment, though nurses provide most of the 
hands-on education, counseling, and support to patients (Park & Larson, 2016).  
State of the Self-Management Science in COPD 
Evidence suggests self-management is significantly associated with reduced hospital 
admissions, improved shortness of breath, and improving quality of life in people living with 
COPD (Andenaes et al., 2014; Trappenburg et al., 2013; Zwerink et al., 2014). Self-management 
behaviors associated with optimal health outcomes in COPD include daily monitoring and 
response to symptoms, smoking cessation, adherence to the medication regimen, engagement in 
physical activity, monitoring of mood, and maintenance of relationships (Balkissoon, 2016; 
Effing et al., 2016; Nici et al., 2014; Rice et al., 2014). People with COPD have complex medical 
and emotional needs, making self-management particularly challenging. Thus, collaboration 





necessary for successful self-management and achieving shared goals of care (Rice et al., 2014). 
The “team-based” approach to self-management, known as collaborative self-management 
(Bourbeau & van der Palen, 2009) is integral to the multicomponent care approach for COPD 
(Halding & Grov, 2017). Interventions to improve engagement in self-management by those with 
COPD have been a research priority in the past decade, reflected in the qualitative and 
quantitative literature (Effing et al., 2016; Jonkman et al., 2016).  
Systematic reviews and meta-analyses.  Five systematic reviews and meta-analyses 
were analyzed in this literature review. Most revealed positive effects of collaborative self-
management interventions on dyspnea control, decreased healthcare utilization (hospital 
admissions and total hospital days for respiratory causes), and improved perception of health 
(Harrison, Janaudis-Ferreira, Brooks, Desveaux & Goldstein, 2015; Jonkman et al., 2016; Kruis 
et al., 2013). However, authors found it difficult to draw any tangible conclusions for clinical 
practice from the randomized control trials examined (Harrison et al., 2015; Jonkman et al., 
2016; Kruis et al., 2013; Zwerink et al., 2014). The same authors reported high heterogeneity 
within the self-management interventions delivered and among the outcome measures. These 
factors and inadequate statistical power prevented pooling of data for analysis to determine the 
most effective approaches for collaborative self-management of COPD (Harrison et al., 2015; 
Jonkman et al., 2016; Kruis et al., 2013; Zwerink et al., 2014). Furthermore, the authors 
concluded that insufficient evidence existed to explain the characteristics of responders from 
non-responders across studies reviewed (Zwerink et al., 2014; Kruis et al., 2013). Authors called 
for greater description of the characteristics of study participants to identify factors associated 






 Randomized control intervention trials. Numerous randomized control trials of 
collaborative self-management interventions have been conducted. Unfortunately, health 
outcome results have been highly variable (Benzo et al., 2012; Bucknall et al., 2012; Rice et al., 
2010; Titova et al., 2017), including adverse events (Fan et al., 2012). As discussed in the 
published meta-analyses and systematic reviews, randomized control trials have been 
inconclusive in identifying and validating effective means to affect self-management behaviors 
necessary to improve COPD health outcomes (Bucknall et al., 2012; Fan et al., 2012). However, 
some were successful in improving health outcomes that matter most to patients, namely dyspnea 
control, mastery of the disease, and quality of life (Benzo et al., 2012, Rice et al., 2010). 
Unfortunately, these studies were viewed as negative because they did not achieve their primary 
aims of improved exercise capacity or decreased all-cause mortality. While no single cause of 
negative results or adverse events were identified, authors of some of the studies posited that 
some participants with COPD might simply not have been capable to self-manage (Bucknall et 
al., 2012; Fan et al., 2012). The mixed results of these studies may suggest that the 
heterogeneous, complex nature of COPD might undermine any intervention that is not 
effectively tailored to the capabilities of the individual. 
 Self-management engagement.  Several qualitative studies have examined the factors 
people with COPD attribute to their engagement in self-management behaviors (Benzo, 
Wetzstein, Neuenfeldt & McEvoy, 2015; Chen, Chen, Lee, Cho & Weng, 2008; Disler et al., 
2012; Sohanpal, Seale & Taylor, 2012). Less than one-half of people with COPD engage in the 
recommended self-management practices (Bender, 2014; Nici et al., 2014). Those who do self-
manage prioritize what they do based upon the most significant burdens the disease places on 





Chen et al. (2008) conducted a qualitative study to describe the self-management 
behaviors people with COPD found most important to integrate into their daily lives. In their 
sample the self-management behaviors that carried the most meaning were symptom 
management (primarily dyspnea and fatigue), being physically active to support regular daily 
activities, making healthy lifestyle choices (e.g., smoking cessation, good nutrition), keeping 
emotions in check, and controlling their environment (avoiding cold). Sohanpal et al. (2012) 
sought to understand the reasons people with COPD either regularly attended or skipped 
collaborative self-management programs. They found that people who were more motivated and 
had prior COPD knowledge were most engaged in attending group-based, peer led programs. 
Participants acknowledged that programs tailored to their strengths and supported their 
capabilities kept them wanting to come back and be engaged (Sohanpal et al., 2012). This view 
from the participants is not surprising, as individualized strengths-based approaches to self-
management optimize an individual’s patient activation level for self-care (Hibbard & Greene, 
2014). When people are offered self-management education and support matched to their current 
capabilities they are more likely to be adherent to recommended self-management behaviors 
(Jonkman et al., 2016).  
Sohanpal et al. (2012) found feeling too ill was the primary deterrent for patients to 
attend self-management programs following hospitalization for COPD exacerbations. 
Alternatively, people who felt too well following hospital discharge indicated their quick 
recovery as a motivational barrier to attendance. Other barriers included logistical factors 
(distance and travel challenges), physical limitations (weakness and portable oxygen burden), 
and emotional struggles (Sohanpal et al., 2012). In 2015 Benzo et al. found similar barriers to 





revealed prevailing factors patients provided for not wanting to attend a pulmonary rehabilitation 
program, such as lack of interest, feeling too ill or frail, being “too busy” to attend, travel 
difficulties, and lack of social support (Benzo et al., 2015). These qualitative studies illuminated 
the diverse challenges to self-management engagement perceived by people living with the 
disease. The breadth of barriers is congruent with the multifactorial, holistic impact of COPD 
(Jerant, van Friederichs-Fitzwater & Moore, 2005). Unfortunately, this heterogeneity prevents 
identification of tangible intervention targets to circumvent lack of self-management engagement 
by people with COPD (Kaptein et al., 2014). However, the results of these studies speak to the 
need of examining factors that contribute to engagement and activation to self-manage in a 
conceptually organized manner to achieve understanding of the findings for practice and research 
advancement. 
 Self-management in COPD.  Over the past two decades systematic reviews and meta-
analyses provided a lens to view the large literature base of self-management science in COPD. 
Self-management is integral to the treatment of COPD and successful engagement is associated 
with better function and quality of life of those with the disease. The high heterogeneity found in 
COPD self-management trial intervention designs, outcomes measured, and study results 
undermine the ability to draw conclusions and establish an evidence base for practice (GOLD, 
2018; Nici et al., 2014; Rice et al., 2014). However, it is important to acknowledge that the self-
management interventions studied were necessarily multicomponent to address the 
multidimensional approach required to treat COPD. Moreover, the heterogeneity of outcomes 
chosen to measure intervention effectiveness is a common problem in self-management science 





 The state of the science reflects poor understanding of the unique patient characteristics 
associated with self-management success and risk for failure (Nici et al., 2014; Titova et al., 
2017). What is known from review of the literature is passive education to acquire disease 
knowledge and action plans for self-treatment of exacerbations are not sufficient to support 
COPD patients to self-manage (Bodenheimer, Lorig, Holman & Grumbach, 2002; Jonkman et 
al., 2016; Kaptein et al., 2014; Trappenburg et al., 2013). Collaborative self-management plans 
must be designed to engage people at a level appropriate to their functional, psychosocial, and 
cognitive/behavioral capability (Grady & Gough, 2014). Active, individualized interventions that 
include bio-physiological management and the role of cognition and emotions are needed 
(Kaptein et al., 2014). Some authors concluded that cognitive-behavioral influences might be at 
the heart of self-management capacity for those with COPD (Kaptein et al., 2014; Korpershoek 
et al., 2016). Thus, studies that examine behavioral constructs associated with self-management 
capacity, such as engagement, motivation, and patient activation, are needed to advance patient-
centered COPD self-management interventions (Korpershoek et al., 2016). Recently, patient 
activation was included as an outcome measure in a COPD self-management intervention trial 
(Titova et al., 2017). Adoption of patient activation as a core outcome measure in this population 
has yet to be reported in the COPD literature.  
Patient Activation 
 Patient activation emerged as a conceptual focus of health care consumerism and 
engagement research to examine factors influencing self-management outcomes in the growing 
population of people with chronic diseases (Hibbard et al., 2016). In 2004 Hibbard, Stockard, 
Mahoney, and Tusler examined the concept of patient activation using the Delphi technique to 





activation for use in clinical and research settings. The authors credit theoretical influences from 
Bandura’s (1991) social cognitive theory, Di Clemente et al.’s (1991) Transtheoretical Model of 
Change, and Wallston, Stein and Smith’s (1994) health locus of control as shaping the item pool 
used in their Delphi approach. They conceptualized and operationalized an individual’s capacity 
to engage in self-care behaviors in chronic disease as patient activation. Patient activation is 
defined as a measure of self-management capacity, reflecting the skills, knowledge, and 
confidence to actively engage as a self-manager (Hibbard et al., 2004).   
 Though Hibbard’s (2004) work is considered seminal in introducing the concept of 
patient activation in the chronic disease literature, the term first appeared in 1982. Morisky, 
Bowler, and Finlay (1982) described increased patient activation, subsumed as being comprised 
of locus of control, knowledge, and compliance, as the outcome of a cognitive-behavioral 
intervention to increase patient engagement in hypertension self-management activities. Though 
pre-dating Hibbard et al. (2004), Morisky et al.’s (1982) description of patient activation quite 
similarly includes knowledge, skills—demonstrated by compliance to carry out actions to 
manage and confidence to take control over their disease management. Interestingly, Hibbard et 
al., (2004) did not include Morisky et al.’s (1982) work as a reference in their paper. The term 
appears again in 1998 in Wagner’s Chronic Care Model (Wagner, 1998). Here, the informed 
activated patient is an integral element of the coordinated process of delivering chronic disease 
care to achieve optimal health outcomes (Wagner, 1998). 
 Since the inception of the first 22-item Patient Activation Measure in 2004, more than 
200 peer-reviewed research papers have been published examining patient activation as: (a) a 
valid assessment tool for self-management capacity; (b) a framework for designing and 





(c) a valid and reliable outcome measure and predictor of health outcomes across multiple 
chronic conditions, age, and sociodemographic groups (Hibbard et al., 2015; Moore et al., 2016; 
Skolasky et al., 2011). The growing evidence base suggests that people with higher patient 
activation levels have better health outcomes in the context of chronic illness; however, the 
factors that determine or mediate patient activation within individuals are still relatively 
unknown (Hibbard et al 2015; Schmaderer, Zimmerman, Hertzog, Pozehl & Paulman, 2016).  
 Patient activation and self-management. Several relationships exist among self-
management behaviors by people with chronic disease and patient activation. Symptom 
monitoring and medication adherence were associated with higher patient activation (Dixon et 
al., 2009; Graffingna et al., 2017; Hibbard & Tusler, 2007). Maintaining a healthy weight, 
following exercise regimens, and attending healthcare appointments were also associated with 
higher patient activation (Bolen et al, 2014; Hibbard et al., 2007; Wong, Peterson, & Black, 
2011).  
 Four studies discussed self-management activities related to chronic lung diseases and 
patient activation. Hibbard and Tusler (2007) explored adult asthma, self-management behaviors, 
and relationships among these with patient activation. They found that knowledge of how to 
respond to an asthma attack and use of stress management skills in the setting of symptom 
change were significantly related to higher patient activation levels in their sample. Two studies 
in this review found the degree of medication adherence to control shortness of breath and 
wheezing was directly related to patient activation levels (Mosen et al., 2007; Skolasky et al., 
2010). Among a cohort of working adults with COPD, Fowles et al. (2009) identified a strong 
association between patient activation level and reported self-management activities focused on 





 Intervention studies have emerged examining the effects self-management support 
programs tailored to the level of patient activation on chronic disease health outcomes. Self-
management studies utilizing patient activation-tailored interventions in heart failure, diabetes, 
and multimorbidity found statistically significant improvements in patient activation level, 
engagement in self-management behaviors, and health outcomes (Bolen et al., 2014; Deen, Lu, 
Rothstein, Santana & Gold, 2010; Hibbard et al., 2007; Hibbard, Greene & Tusler, 2009; 
Ryvicker, Feldman, Chiu & Gerber, 2013; Shively et al., 2013; Van Do, Young, Barnason & 
Tran, 2015). The utility of patient activation in these studies was demonstrated two-fold. First, 
interventions were tailored to the current patient activation level of the participants. A step-wise 
approach to delivering the intervention aimed to build confidence in patients to self-manage was 
consistent with the theoretical influences underpinning the conceptual definition of patient 
activation (Shively et al., 2013). Second, the sensitivity of the PAM allowed for determining 
correlations among patient activation change and health outcome change in the samples studied. 
Most patient activation-tailored intervention studies showed positive relationships among self-
management interventions and improved outcomes—health and patient activation level (Deen et 
al., 2010; Hibbard et al., 2009; Shively et al., 2013), but others showed no change in patient 
outcomes (Bolen et al., 2014; Ryvicker et al., 2013; Titova et al., 2017).  
 The mixed findings of patient activation-tailored self-management trials are congruent 
with the crux seen in the COPD self-management intervention literature. It is unclear why some 
patient activation-tailored self-management interventions were not effective in changing 
behavior. Knowledge that patient activation level is modifiable (Hibbard & Greene, 2013) and 
responsive to strengths-based approaches to self-management support (Hibbard & Mahoney, 





patient activation within people who have chronic disease. Interest in understanding the 
complexity underpinning patient activation development in individuals has led to several studies 
examining the determinants of patient activation level in people with chronic diseases. 
Determinants of Patient Activation in Chronic Disease 
Examining the impact of demographic, psychosocial, and disease-specific factors 
influencing the development of patient activation among people with chronic disease has become 
a recent focus of nursing inquiry. Several studies have examined a variety of patient-centered 
factors as correlating to or predictors of patient activation level (Bos-Touwen et al., 2015; Chen, 
Chen, Lee, Cho & Weng, 2014; Chubak et al., 2012; Goodworth et al., 2014; Korpershoek et al., 
2016; Mazanec, Sattar, Delaney & Daly, 2016; Schmaderer et al., 2016). Secondary goals of 
these studies were to understand the potential risk factors for limited self-management capacity 
and, thus, illuminate modifiable targets for individualized approaches to self-management 
interventions.  
Some studies identified a theoretical framework as underpinning variable choice, study 
design, or framing the results (Chen et al., 2014; Chubak et al., 2012; Goodworth et al., 2014). 
The Andersen Behavioral Model (Chen et al., 2014) and Chronic Care Model (Chubak et al., 
2012) have healthcare delivery systems and environments at their core. Thus, the studies were 
limited to examining environmental factors influencing patient activation level, not including the 
impact of chronic disease on individuals. Similarly, the internal, cognitive processes of Self-
Efficacy Theory limited the study of determinants by Goodworth et al. (2012) to inclusion of 
individual characteristics and disease-specific health outcomes. Other studies examined variables 
found to be relevant to health outcomes in the disease-specific literature of their populations of 





al., 2016; Mazanec et al., 2016; Schmaderer et al., 2016). Both approaches to the study of 
determinants of patient activation yielded a diverse array of variables for examination. 
 Disease-specific determinants. Determinants of patient activation within specific 
chronic diseases have been studied. Chen and colleagues (2014) examined a national sample of 
people with depression to identify contextual factors associated with mental healthcare 
utilization. These factors formed the basis of a framework for explaining determinants of patient 
activation level in this population. Through multivariate regression, characteristics of the 
environment in which people lived and site of usual health care (local primary care clinic) were 
significant in predicting higher levels of patient activation, explaining 15% of the variance in 
patient activation scores. Goodworth et al. (2014) based their cross-sectional study of persons 
with multiple sclerosis on Bandura’s self-efficacy theory, noting Hibbard and Mahoney’s (2010) 
assertion that efficacy is necessary to establish one’s concept as a self-manager in chronic 
disease. They examined mood, self-efficacy in multiple sclerosis, quality of life, and 
sociodemographic factors through hierarchical regression modeling. Self-efficacy and 
educational level were positively related to patient activation level, while depression was 
negatively related to patient activation level. These variables explained 35% of the variance in 
patient activation level in their sample. O’Malley and colleagues (2017) examined patient 
characteristics and clinical factors as determinants of patient activation among prostate and 
breast cancer survivors. Results from their cross-sectional survey indicated race, marital and 
employment status, income, and ease of access to their healthcare providers were significantly 
positively associated with patient activation level among prostate cancer survivors, but only 
provider access and time spent with them were positive predictors among breast cancer 





analysis of variance, however, the assertions of these factors as predictors of patient activation 
are unsubstantiated by the lack of linear regression used in the statistical analysis.  
 In these studies the variables examined and shown to predict patient activation among 
community-dwelling adults are congruent with Ferrans et al.’s (2005) definitions of 
characteristics of the individual and the environment and their assertion that these characteristics 
can directly influence health outcomes in chronic disease. Thus, these disease-specific studies 
suggest that characteristics of the individual (Goodworth et al., 2014; O’Malley et al., 2017) and 
their environment (Chen et. al., 2014; O’Malley et al., 2017) are important factors to consider in 
examining determinants of patient activation among people with COPD. 
 Disease transcending determinants. Other studies used cross-sectional design to 
investigate disease-transcending determinants of patient activation across multiple chronic 
conditions (Bos-Touwen et al., 2015; Schmaderer et al., 2016). Bos-Touwen et al. (2015) 
examined 19 clinical, demographic, and psychosocial determinants of activation in a cross-
sectional survey study of patients with chronic renal, heart, pulmonary, or endocrine diseases. 
Through multivariate regression analyses, the authors found that disease severity, health-illness 
perceptions, mood, social support, sociodemographic factors, and co-morbidity impact explained 
16% of the variance in activation levels across chronic disease sub-groups (Bos-Touwen et al., 
2015). Schmaderer et al. (2016) explored demographic, psychosocial, and clinical factors as 
determinants of patient activation level among people with multimorbidity. The authors included 
commonly used patient-reported outcomes tools (i.e., PACIC, PROMIS-29, EuroQOL 5) to 
survey patients just prior to discharge for hospitalizations resulting from exacerbation of one of 
more chronic conditions. Multivariate regression yielded three factors explaining 26% of the 





with one’s social role, and level of involvement in chronic illness care team (Schmaderer et al., 
2016). These two studies examined highly heterogeneous factors across multiple disease states as 
possible determinants influencing patient activation in chronic disease. The independent 
variables examined in these studies aligned with each of the domains described in the Revised 
Wilson Cleary Model (Ferrans et al., 2005), adapted to guide this study. Interestingly, the 
predictors identified were reflected in each of the domains of the Revised Wilson Cleary Model 
(Ferrans et al., 2005), except symptoms and overall quality of life. The results offer that complex 
and highly integrated factors influence patient activation level among people living with 
multimorbidity. The disease-transcending determinants of patient activation were relevant to the 
design of this study, as most people with COPD have at least two other co-morbid chronic 
conditions (Benzo et al., 2010; Celli et al., 2015).  
Longitudinal studies of determinants. Building on the frequently used, cross-sectional 
approach, longitudinal studies were conducted to examine disease-transcending determinants of 
patient activation. Chubak et al., (2012) followed older adults with diabetes and heart disease 
over one year as part of an integrated health delivery system. Self-rated health, serious adverse 
events from chronic disease (e.g., ED visits, hospitalizations), satisfaction with chronic disease 
care, patient activation, and measures of disease impact was collected via a survey during 
Medicare enrollment visits. Though many of the variables were correlated, only older age and 
worse self-rated health (i.e., Fair or Poor) were independent predictors of decreased patient 
activation level from baseline to one year (Chubak et al., 2012). Hibbard et al. (2015) published a 
report examining patient activation level as a predictor of health outcomes over time. Participants 
were reexamined four years after first response to a national panel survey of people with diverse 





function, and decreased costly health care use were enduring outcomes of high patient activation 
at baseline (Hibbard et al., 2015). When patient activation changed over the four-year period, it 
did so with health outcomes moving in the same direction (e.g., activation increased, positive 
outcomes occurred; activation decreased, negative outcomes occurred). Congruent with Chubak 
et al.’s (2012) findings, older age and poorer general perception of health were strongly 
associated with lower patient activation scores (Hibbard et al., 2015). Recently, Mazanec and 
colleagues (2016) studied relationships among symptoms, mood, physical and role function, and 
patient activation before and four months after surgery among colorectal cancer survivors. 
Interestingly, they found patient activation to be high (Level 3) and stable across time in this 
population. In linear mixed effects models, negative emotions were significantly associated with 
low patient activation (Levels 1 and 2) across all time points. Their finding is congruent with 
Hibbard and Mahoney’s (2010) cross-sectional study that indicated patient activation is strongly 
linked to the experience of positive and negative emotion in daily life. All the identified 
predictors of patient activation that endure over time among people with chronic conditions align 
with domains of the Revised Wilson Cleary Model (Ferrans et al., 2005), further supporting the 
use of the model in the current study. 
State of the Science for Determinants of Patient Activation 
 The growing body of literature described several determinants of patient activation in 
the setting of community dwelling adults with one or more chronic diseases. Of these, 
demographic and socioeconomic characteristics, mood, role status, social support, perceived 
health status, and the impact of one or more chronic disease were shown in one or more studies 
to predict patient activation level. This evidence provided further support for using the Revised 





this dissertation research. Though correlations could not be drawn across the studies, as each 
examined different variables of interest, age, general perception of health, negative mood states, 
and socioeconomic status appeared most frequent as determinants in multiple studies. Therefore, 
inclusion of these factors was imperative in the study of patient activation predictors in the 
setting of COPD. 
Patient Activation and COPD 
 Little is known about how the complex, systemic nature of COPD affects patient 
activation (Evans & Morgan, 2014; Korpershoek, 2015). Although patient activation can be 
objectively measured with the PAM (2004), it is not typically assessed in COPD clinical visits 
(Korpershoek et al., 2016). Evidence of patient activation as a predictor of chronic disease 
outcomes is particularly relevant in the domain of COPD care. COPD is a resource-intensive 
disease process, imparting high self-care burden on patients and costly health care utilization 
(Celli et al., 2015). Health care utilization rates, including 30-day hospital readmission, and 
health care costs of people with COPD are approximately twice that of healthy age and sex-
matched controls (Green et al., 2015; Mitchell et al., 2014; Roberts et al., 2000). Self-
management has been associated with decreased incidence of hospitalization for acute 
exacerbation of COPD (Zwerink et al., 2014), which is the leading driver of COPD-related costs 
worldwide (Dhamane et al., 2015). Adults with higher activation were more likely to participate 
in recommended activities associated with collaborative self-management treatment plans for 
COPD (Dixon, Hibbard & Tusler, 2009). Charlot and colleagues (2017) found patient activation 
mediated the effect of self-management education on hospitalization rates among urban, 
Caucasian adults. One standard deviation increase in PAM score was associated with 18% 





as a modifiable target to address readmission rates in this population (Charlot et al., 2017). 
Examining how patient activation is influenced in this population is warranted.   
 Determinants of patient activation in COPD. To date, only one Dutch study explored 
determinants of self-management capacity, operationally defined as patient activation, among 
people living with COPD. The work by Korpershoek et al. (2016) utilized a cross-sectional 
survey design with electronic medical data abstraction to identify COPD-specific determinants of 
self-management capacity. The sample (N = 296) included adults with COPD living in the 
community and in skilled nursing facilities. Fifteen independent variables were chosen from the 
extant COPD literature (Korpershoek et al., 2016), which reflected a diverse examination of 
biological, behavioral, and psychosocial factors influencing self-management capacity. 
Multivariate logistical regression analyses revealed six determinants explaining 17% of the 
variance in self-management capacity; these included anxiety, illness perception, Body Mass 
Index, COPD severity, comorbidities, and age (Korpershoek et al., 2016). It is important to note 
that Korpershoek’s study cohort was included in the previously described multi-chronic disease 
study of Bos-Touwen et al. (2015).  
 Korpershoek et al.’s (2016) work provides seminal insight to the individual patient 
characteristics associated with patient activation among people with COPD. Several of these 
predictors were included in the current study. Though Korpershoek et al.’s (2016) sample was 
large, inclusion of participants living in skilled care environments who were not independently 
responsible for managing their treatment plan raised questions to the meaning of the results. Self-
management of chronic disease is a phenomenon of community dwelling persons, not typically 





Therefore, this study of determinants of self-management capacity focused on people with 
COPD who were independent in their health management.  
Outcomes of COPD and Patient Activation Via the Revised Wilson Cleary Model 
Patient activation is a multidimensional, patient-reported health outcome in chronic 
disease. Though theoretically influenced by several behavioral frameworks (Hibbard et al., 
2004), a conceptual or theoretical framework describing the process of patient activation in 
individuals and populations with chronic disease has yet to be reported in the literature. Thus, 
adaptation of existing theoretical and conceptual frames would be needed to examine the concept 
in the context of specific diseases. The Revised Wilson Cleary Model (Ferrans et al., 2005) is a 
descriptive, explanatory framework that categorizes personal and health phenomena and 
proposes relationships between and among these phenomena (Tappen, 2016). The model and the 
original work by Wilson and Cleary (1995) were described in detail in Chapter I. The existing 
evidence of relationships among health outcomes, characteristics of people with COPD, and 
shared associations with patient activation, will be organized within the domains of the Revised 
Wilson Cleary Model (Ferrans et al., 2005). Further, evidence of the application and adaption of 
the conceptual framework in similar empirical research is presented. 
Characteristics of the Individual  
Characteristics of the individual are the demographic, developmental, psychological, and 
biological factors that influence health outcomes in chronic disease (Ferrans et al., 2005). These 
characteristics impact all antecedents of quality of life in the Revised Wilson Cleary Model 
(Ferrans et al., 2005), and may moderate relationships among the health outcomes as well. In this 
study, specific demographic, psychological, and biological factors were selected as important 





 Demographic factors. Age is negatively associated with COPD health outcomes 
(Croft, et al., 2018) and patient activation level (Dunlay, Griffin, Redfield & Roger, 2017; 
Hibbard et al., 2015; Korpershoek et al., 2016). Evidence offers several gender differences in 
expression of symptoms, disease progression, and exacerbation trajectories, favoring greater 
morbidity and mortality for women with COPD (Balkissoon, 2011; Pruitt, 2014; Jenkins et al., 
2017). Inconsistent relationships between gender and patient activation level have been 
identified. Several studies suggested women are more activated than men (Fowles et al., 2009; 
Hibbard, Mahoney et al., 2005; Hibbard, Greene et al., 2015; Young et al., 2017), although 
Lubetkin, Lu, and Gold (2010) found the opposite to be true. Authors recommended the role of 
gender and patient activation should be considered cautiously, as many published patient 
activation studies had disproportionately large numbers of women in their samples (Fowles et al., 
2009; Goodworth et al., 2016; Hibbard et al., 2005, 2007, 2015, 2016).  
 Race and ethnicity associations with health outcomes in COPD are thought to be largely 
a component of socioeconomic status (GOLD, 2018; Mannino et al., 2014), as COPD is most 
prevalent among white, non-Hispanics in America (Croft et al., 2018; Tilert et al., 2013). Low 
socioeconomic status has been associated with limited functional status and poorer lung function, 
thus, imposing risk for increased COPD severity and acute exacerbations (Dhamane et al., 2015; 
Eisner et al., 2011). Racial and ethnic minorities have demonstrated lower levels of patient 
activation than their Caucasian counterparts (Alexander, Hearld, Mittler & Harvey, 2012; 
Hibbard et al., 2007; Hibbard & Cunningham, 2008; Lubetkin et al., 2010). Like the health 
outcomes in COPD, more recent literature argued that socioeconomic status better explains the 
variance in patient activation level among these groups (Hibbard et al., 2015; O’Malley et al., 





 Educational level (GOLD, 2018; Eisner et al., 2011), increased health literacy, 
(Ryvicker et al., 2013; Smith, Curtis, Wardle, von Wagner & Wolf, 2013), and greater self-
management engagement (Lorig & Holman, 2003; Trappenburg et al., 2013) were positively 
correlated with better health outcomes in COPD and patient activation levels (Bos-Touwen et al., 
2015; Fowles et al., 2009; Hibbard et al., 2007, 2015; Marshall et al., 2013). Limited education 
attainment and income were independently related to greater risk of acute COPD exacerbation 
when controlling for race and ethnicity (Eisner et al., 2011).  
 Employment has also been positively correlated with patient activation levels, self-
management engagement, and positive health outcomes in COPD (Eisner et al., 2011; Fowles et 
al., 2009; Grodner et al., 1996; Smith et al., 2000). Among older adults with COPD, participating 
in paid work was associated with greater perception of physical health and quality of life 
(Andenæs, Bentsen, Hvinden, Fagermoen & Lerdal, 2014). Earned income, a measure of 
socioeconomic status resulting from employment, has been correlated with engagement in health 
care activities (e.g. seeing a health care provider, following treatment plans, compliance with 
medication regimens) and self-reported health among adults with COPD (Eisner et al., 2011; 
Fowles et al., 2009; Steer, Gibson, & Bourke, 2010).  
Psychological factors. Positive and negative affect are inextricably linked to comorbid 
mood disorders and health outcomes in COPD and patient activation. Anxiety, a negative affect 
state (Cohen & Pressman, 2006), can be both comorbidity and symptom of COPD (Yohannes & 
Alexopoulos, 2014), directly influencing the symptom of dyspnea (Carrieri-Kohlman et al., 
2010).  Clinical depression and depressive symptoms are also associated with negative affect or 
mood (Cohen & Pressman, 2006). Comorbid depression and anxiety often appear together in 





Negative affective arousal induces sympathetic responses of increased breathing and heart rate, 
exacerbating the sensation of dyspnea and feelings of fear in people with COPD (Cohen & 
Rodriguez, 1995). In turn, strong negative emotional responses to dyspnea provoke increased 
attention to breathing, inducing further anxiety, and yielding avoidance behaviors. The resulting 
vicious negative cycle erodes functional performance (DiNicola, Julian, Gregorich, Blanc & 
Katz, 2013; Nguyen, Donesky-Cuenco & Carrieri-Kohlman, 2008) and quality of life among 
people with COPD (Carrieri-Kohlman et al., 2010; Norweg & Collins, 2013).  Benzo, Abascal-
Bolado and Dulohery (2016) found positive affect, manifested as feelings of optimism and 
happiness, to be independently associated with quality of life and mediated the relationship 
between self-management ability and quality of life among adults with COPD.   
Positive affect has been associated with higher patient activation levels and engagement 
in self-management behaviors by people with chronic disease (Charlson et al., 2014; Hibbard & 
Mahoney, 2010; Graffigna et al., 2017). Several studies have shown that negative affect states, 
such as anxiety and depression, are prevalent among people reporting lower activation scores 
(Gerber et al., 2011; Hibbard & Cunningham, 2008; Hibbard & Mahoney, 2010; Smith et al., 
2013). Further, researchers have found that people with negative affect and concomitant low 
patient activation scores were more likely to have been hospitalized or visited an emergency 
department, than those with positive affect states (Greene & Hibbard, 2012; Hibbard et al., 
2015).  
Biological factors. Increased Body Mass Index is a biological factor associated with 
negative health outcomes (Eisner et al., 2011; Steer et al., 2010) and decreased patient activation 
levels of people with COPD (Korpershoek et al., 2016; Liu et al., 2014). The length of time 





et al., 2010) and increased COPD-related morbidity (GOLD, 2018). Similarly, the length of time 
with chronic disease is associated with fluctuations in patient activation level (Chubak et al., 
2012; Hibbard et al., 2015; Skolasky et al., 2011). The longer people live with COPD, the greater 
the incidence of exacerbations, diminished function, and reports of negative quality of life 
(Andenæs et al., 2014; Balkissoon, 2016; Benzo et al., 2010). Disease burden and exposure to 
care providers, rehabilitation services, and disease-specific education, over time are factors that 
may influence patient activation level of people living with COPD (Hibbard et al., 2007).  
Characteristics of the Environment 
 Characteristics of the environment are the social interactions and physical surroundings, 
which influence the individual’s perception of quality of life in the context of chronic disease 
(Ferrans et al., 2005). Friends, family, and caregivers represent the interpersonal and social 
influences of health within one’s environment. The physical setting in which one lives, works, 
and engages socially influences health outcomes (Ferrans et al., 2005). Previous studies in COPD 
self-management and patient activation proposed that where people live (rural or urban) and 
whom they live with (alone or with significant others) are relevant characteristics of the 
environment influencing health outcomes. 
 Limited access to care providers and COPD resources (i.e., pulmonary rehabilitation or 
Better Breathers Groups) in rural areas have been implicated as causal factors for increased risk 
of COPD exacerbations and exacerbation-related mortality (Croft et al., 2018; NQMC, 2017). 
Older adults living in rural settings report low patient activation scores (Young et al., 2017). 
Relationships with physicians (Alexander et al., 2012; Wong et al., 2011), satisfaction with 
overall chronic disease care (Boyd et al., 2014), and increased access to primary care within the 





patient activation levels. These factors were also associated with improved self-management 
among people living with COPD and heart failure (Dunlay et al., 2017; Van Do et al., 2015). 
Increased patient activation levels and improved health outcomes among older people living in 
urban, metropolitan settings were attributed to greater access to health care and less social 
isolation (Chen et al., 2014). Others found conflicting results, despite increased concentration of 
resources; older chronically ill adults living in inner-city settings also reported lower patient 
activation levels (Maranda, Deen, Elshafey, Herrera & Gold, 2014). In contrast, other authors 
described limited health care access and isolation as contributing to lower patient activation 
scores among older adults living in rural settings (Young et al., 2017).  
 Marital status and living arrangements are relevant to the social support and health 
outcomes of people with COPD and have been associated with patient activation levels. Social 
support is positively correlated with maintaining daily physical activity following pulmonary 
rehabilitation programing and decreased morbidity and mortality following hospitalization for 
exacerbation among adults with COPD (Meshe, Claydon, Bungay & Andrew, 2017). Social 
support has been positively correlated with patient activation and engagement in self-
management activities across chronically ill populations (Bos-Touwen et al., 2015; Fowles et al., 
2009; Hibbard & Cunningham, 2008; Hibbard et al., 2007). Living alone has been associated 
with lower patient activation levels (Fowles et al., 2009; Korpershoek et al., 2016), frequent 
health care utilization (Roberts et al., 2016), and increased risk of exacerbation requiring 
hospitalization among people with COPD (Dhamane et al., 2015).  
Biological Function 
 Biological function broadly reflects the dynamic processes that support life (Wilson & 





are impacted by disease (Ferrans et al., 2005). Ferrans et al. (2005) assert that progressive 
biological dysfunction can directly or indirectly affect all other domains of health, thus 
optimizing biological function is integral to achieving a state of health within illness. COPD is a 
multifaceted lung disease characterized by progressive obstruction within the airways and 
damage to the lung parenchyma (Balkissoon et al., 2011). Spirometric measures of lung function 
reflected the objective measure of biological function in this study. 
 Lung function and disease severity. Spirometry is a breathing test that evaluates ease 
and volume of airflow through the lungs and airways. FEV1 less than 80% of predicted volume 
of airflow, based on gender, race, height, weight, and age, is a diagnostic criterion of COPD 
(Celli et al., 2015; GOLD, 2018). COPD severity is classified by FEV1 values in the Global 
Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD, 2018). GOLD 
(2018) classifies COPD by four stages of severity: (a) COPD stage 1: mild (FEV1 <80% 
predicted), (b) COPD stage 2: moderate (FEV1 50-80% predicted), (c) COPD stage 3: severe 
(FEV1 30-50% predicted) and (d) COPD stage 4: very severe (FEV1 <30% predicted). 
Spirometry was chosen as the biological variable of interest in this study as measures of airway 
obstruction are: (a) a diagnostic and staging requirement for COPD, (b) central to treatment 
recommendations, and (c) integral to characterizing the sample in the COPD literature. 
 Celli et al. (2015) have stated that biological function, assessed by FEV1, does not fully 
explain the impact of COPD on health outcomes (Celli et al., 2015). Airflow obstruction has 
been poorly correlated with dyspnea, exercise tolerance, and health-related quality of life across 
several studies (Benzo et al., 2010; Bucknall et al., 2012; Guyatt et al., 2007). However, Tsukino 





people living with COPD. Severity of COPD, categorized by FEV1, was found to be a predictor 
of patient activation level in people with COPD by Korpershoek et al. (2016).   
Symptoms 
Symptoms reflect a person’s perception of an abnormal physical, emotional, or cognitive 
state (Ferrans et al., 2005; Wilson & Cleary, 1995). Symptom assessment and management are 
crucial activities in self-management of COPD, shifting the focus of care from “cellular and 
organism level to a (whole) person level.” (Ferrans et al, 2005, p. 339). Dyspnea and fatigue are 
the two most common and progressive symptoms experienced by people with COPD (Peters et 
al., 2010; Tel et al., 2012). Minimizing symptom burden is essential to maintaining quality of 
life, thus a priority in COPD treatment plans (van der Molen, Miravitlles & Kocks, 2013).  
 Biomedical treatments are focused on controlling dyspnea caused by airway 
inflammation and reactivity through use of pharmaceuticals, prevention of opportunistic 
infections, and strengthening the respiratory and large muscle groups (Qaseem et al., 2011). 
Research proposed the physiological mechanisms impacting the perception of dyspnea and 
fatigue by people with COPD contribute to declining function and quality of life (Paes et al., 
2015). Fatigue is prevalent among people living with COPD; nevertheless, the mechanism of 
fatigue is poorly understood (Walke et al., 2007). Fatigue is strongly associated with dyspnea 
(Kapella et al., 2006) and low self-rated health (Nguyen et al., 2008) in this population.  
Symptoms in COPD have been associated with negative outcomes across multiple 
domains of the Revised Wilson Cleary Model (Ferrans et al., 2005). Liu et al. (2014) found older 
adults with COPD were more likely to have difficulty with at least one instrumental activity of 
daily living and less likely to engage in social activities due to dyspnea and fatigue, as compared 





COPD. Bentsen, Henriksen, Wentzel-Larsen, Hanestad, and Wahl (2008) found mood 
symptoms, such as depression and anxiety, and dyspnea explained 35%-51% of the variance in 
self-rated health among people with COPD, as compared to the general population. More 
recently, Marvel and colleagues (2016) reported that symptoms significantly contributed to lower 
self-rated health and satisfaction with role function, even when patients received the standard of 
care for COPD, which included collaborative self-management support.  
Symptom monitoring and activities to control or alleviate symptom burden are basic 
elements of self-management in chronic disease. However, symptoms and their relationship with 
patient activation have been minimally described in the literature. Kukla, Salyers and Lysaker 
(2013) examined the relationship between patient activation and symptoms among adults with 
schizophrenia. They found that people who experienced emotional discomfort symptoms (e.g., 
hopelessness, depression) attributed to living with chronic mental illness, reported lower patient 
activation scores than counterparts with physical chronic diseases and associated physical 
symptoms (Kukla et al. 2013). Dyspnea, fatigue, and pain symptoms were also found to be 
related to, but not predictive of activation level, in studies of patient activation determinants 
(Bos-Touwen et al., 2015; Korpershoek et al., 2016; Schmaderer et al., 2016).  
Functional Status 
 Functional status represents a person’s ability to perform tasks in multiple domains 
reflecting adequate physical, social, role, and emotional capacity (Ferrans et al., 2005). 
Functional capacity describes one’s capability to perform specific physical, social, emotional, or 
cognitive tasks, whereas functional performance reflects the actions performed in daily life 
(Wall, 2007). The physical and role domains of functional status, as defined by Ferrans et al. 





The negative effects of COPD reach far beyond the respiratory tract, thus posing 
significant threats to functional status. Comorbid cardiovascular disease, emotional vulnerability, 
peripheral and respiratory muscle wasting, and sedentary, socially isolated lifestyle contribute to 
impaired function as COPD progresses (Carrieri‐Kohlman et al., 2010; Monjazebi et al., 2016).  
Concomitant effects of dyspnea and fatigue limit physical activity, leading to systematic 
deconditioning and limited function in daily life (Kapella et al., 2006). Poor functional status is a 
strong predictor of hospitalization and survival in COPD (Reardon et al., 2006). Optimization of 
physical function through self-management (e.g., symptom control, reducing exacerbations, and 
exercise) is critical to maintaining quality of life (Effing et al., 2016; Grodner et al., 1996; Guyatt 
et al., 2007; Liu et al., 2014) and best supported through formal pulmonary rehabilitation 
programming (Balkissoon et al., 2011; Bourbeau & van der Palen, 2009; Steer et al., 2010). 
Pulmonary rehabilitation professionals acknowledge that adequate patient activation is a 
necessary patient characteristic for regaining function through outpatient rehabilitation 
programming (Stoilkova-Hartmann, Janssen, Franssen, Spruit & Wouters, 2015). Supporting this 
assertion, Korpershoek et al. (2016) found that functional status was significantly correlated with 
patient activation level among people with COPD in their sample.  
General Perception of Health 
            General perceptions of health reflect the subjective synthesis of all aspects of health, 
disease, the individual, and their environment (Ferrans et al., 2005; Wilson & Cleary, 1995). 
Integrated physiological and psychosocial factors influence how people living with COPD 
perceive and rate their health (Bentsen et al., 2008). Wilson and Cleary (1995) asserted that self-





“How would you rate your health—excellent, very good, good, fair, or poor?” provides a simple 
and global approach to assessing general perception of health (Ferrans et al., 2005).  
The single question to assess general perception of health has been widely studied in 
COPD. Strong correlations have been identified between symptoms (i.e., dyspnea and fatigue) 
and general perception of health among adults with COPD (Mahler & Mackowiak, 1995; 
Nguyen et al., 2008). Further, diminished physical function from impaired respiration imposes 
negative effects on general perception of health (Nguyen et al., 2008). The global, single 
question assessing self-rated health is an important measure of risk for negative health outcomes 
in COPD. Self-reported health status of fair or poor was found to be an independent predictor of 
hospitalization based on multiple logistic regressions in among patients involved in the medical 
arm of the National Emphysema Treatment Trial (Benzo et al., 2010). The authors reported the 
odds of being hospitalized for COPD were 1.6 times greater among patients who rated their 
health fair or poor as compared to patients rating their health good or very good (Benzo et al., 
2010). Further, self-rated health has been found to independently predict COPD-related mortality 
across diverse epidemiological samples and persists in multivariate models including potential 
confounders, such as medical, behavioral, and psychological risk factors (Benzo et al., 2010; 
Nguyen et al., 2008; Park and Larson, 2016; Wagner & Short, 2014). 
 General perceptions of health while living with COPD may influence self-management 
engagement (e.g., treatment adherence and coping) and thus, directly impact health outcomes 
(Lorig & Holman, 2003). Studies of determinants of patient activation revealed negative 
perception of heath was associated with lower patient activation (Bos-Touwen et al., 2015; 
Chubak et al., 2012; Korpershoek et al., 2016) and positive perception of health with higher 





and Hibbard et al. (2015) found through longitudinal analyses that patient activation levels and 
self-rated health similarly decrease over time in the setting of chronic disease. Progressive 
deterioration of health and diminishing capacity to engage in self-management activities pose 
tangible risk factors for poor health outcomes for people living with COPD.  
Overall Quality of Life 
            Per Ferrans (1990), quality of life is “a person’s sense of well-being that stems from 
satisfaction or dissatisfaction with the areas of life that are important to him/her” (Ferrans, 1990, 
p.15). People with COPD report higher rates of poor overall quality of life as compared to other 
chronic conditions, including heart failure and chronic renal disease (Guyatt et al., 2007). The 
target of COPD treatments and rehabilitation is to improve or maintain quality of life (Celli et al., 
2015).  
 Sexton, Munro, Chang, Woods, and Milde’s (1988) seminal work explored the 
problems women experienced when diagnosed with COPD and the influence of these on overall 
life satisfaction. The participants identified symptoms of: (a) breathlessness and fatigue, (b) 
disease management-induced stress, (c) loss of role identity and fluctuating functional capacity, 
and (d) declining health status as the most significant contributors to diminished life satisfaction 
(Sexton et al., 1988). Later, Hu and Meek (2005) conducted a descriptive correlational inquiry to 
examine the relationships among bio-physiological variables, symptoms status, and quality of 
life in men and women with COPD. Like Sexton et al., (1988), their findings suggested 
symptoms (breathlessness), impaired functional status, and negative mood (affect states) 
significantly and negatively impacted quality of life (Hu & Meek, 2005). Guyatt, Ferrans, and 





Model (Wilson & Cleary, 1995) integrate to influence the individual’s perception of overall 
quality of life.  
 The patient activation literature showed inconsistent relationships between quality of 
life and level of activation. Several studies reported that patients, who indicated they had good 
quality of life, also had higher patient activation scores (Dixon et al., 2009; Goodworth et al., 
2016; Hibbard et al., 2007, 2015; Mosen et al., 2007). It is unclear from the self-management 
literature if better quality of life was a motivating factor for patient activation, and thus self-
management engagement, or if higher activation and subsequent self-management behaviors lead 
to the improved quality of life (Goodworth et al., 2016). Quality of life was notably absent as a 
variable of interest in Korpershoek et al.’s (2016) comprehensive examination of factors 
influencing patient activation level of people with COPD. Schmaderer et al. (2016) did include 
quality of life in their examination of patient activation determinants in people with 
multimorbidity, including COPD. However, they did not find a relationship between quality of 
life and patient activation level (Schmaderer et al., 2016). Regardless of the direction of 
integration and influence, the literature suggests patient activation and quality of life are likely 
related through self-management processes in chronic disease (Dixon et al., 2009). 
Application and Adaptation of the Conceptual Framework 
The literature provided evidence for the application and adaptation of the Wilson Cleary 
Model (Wilson & Cleary, 1995) and Revised Wilson Cleary Model (Ferrans et al., 2005) to 
examine health outcomes. The Wilson Cleary Model (Wilson & Cleary, 1995) has been widely 
applied in COPD health outcomes research, including predictive validity testing (Ade-
Oshifogun, 2012; Arnold, Rancor, Koeter, de Jongste & Sandeman, 2005; Bentsen et al., 2008; 





general perceptions of health among people with COPD. Bentsen et al. (2008) applied the model 
to identify determinants of self-rated health, while Ngyen et al. (2008) used the model to 
explicate relationships between symptoms, function, and self-rated health. Additionally, Arnold, 
et al. (2005) applied the model to examine health and personal factors that influenced subjective 
and objective general perceptions of health in people with COPD and coronary artery disease. 
Ade-Oshifogun (2012) tested the fit of the entire model to predict quality of life among people 
with COPD.  
 The literature revealed examples of studies that adapted the Revised Wilson Cleary 
Model (Ferrans et al., 2005) to study health outcomes relevant to COPD care. Zubritsky et al. 
(2013) adapted and expanded the model to examine impact of cognitive function and long-term 
social supports on quality of life in older adults with multimorbidity. Arbaje et al. (2008) 
modified the model to describe and predict relationships among individual (socioeconomic 
status) and environmental (home arrangement and living status) characteristics, and likelihood of 
early hospital readmission among community-dwelling older adults with chronic disease. Two 
studies tested the explanatory ability of the revised model to identify disease-specific predictors 
of quality of life in adults receiving acute care for chronic conditions (Kring & Crane, 2009; 
Saengsiri, Thanasilp & Preechawong, 2014). Both studies provided evidence of goodness of fit 
of the Revised Wilson Cleary Model (Ferrans et al., 2005) for comprehensive examinations of 
health phenomena important to the development of nursing interventions in supporting chronic 
disease. A weakness of the studies that adapted or utilized only selected domains of the 






 Wilson and Cleary (1995) noted the breadth of domains while Ferrans et al. (2005) 
asserted the fluidity of the model, increased the utility of the conceptual framework in 
examinations of relationships among health phenomena. Thus, the authors have encouraged 
adaptation for application in research. However, the causal relationships implied within the 
models require all domains to be included for examinations of model fit and predictive validity 
involving highly integrated health outcomes (Ferrans et al., 2005). The studies that tested the 
models included predictor variables from all model domains (Ade-Oshifogun, 2012; Kring & 
Crane, 2009; Saengsiri et al., 2014).   
Significant Gaps in Knowledge 
 With the high disease burden, morbidity, and growing mortality associated with COPD 
in the United States, there is a significant need to understand factors that contribute to successful 
engagement in self-management. Descriptions of characteristics of study responders and 
assessments used to individualize interventions to meet participants’ levels of self-management 
capability were missing from the self-management intervention literature. Patient activation has 
emerged as a critical concept in self-management science and predictor of health outcomes in 
chronic disease, yet has been minimally discussed in the COPD literature. One study described 
patient activation among people with COPD (Halding & Grov, 2017), and several did so in the 
context of COPD being a sub-cohort of larger chronic disease studies (Bos-Touwen et al., 2015; 
Greene & Hibbard, 2012; Hibbard et al., 2015; Hibbard et al., 2007; Turner, Anderson, Wallace 
& Kennedy-Williams, 2014). Notably, only one study examined COPD-related patient factors as 
determinants of patient activation in Dutch people with COPD (Korpershoek et al., 2016). This 
study addresses the gap by providing a comprehensive description of patient characteristics, 





Fundamental theoretical knowledge of patient activation was missing from the literature. 
A theoretical or conceptual framework describing patient activation has not yet been published. 
Although Hibbard’s (2004) definition is widely accepted as the only conceptual and operational 
definition of patient activation, concept analyses that examined patient activation or its use in 
nursing or other disciplines have not been reported in the literature. Also missing from the 
literature were theory generating, qualitative studies to explore the lived experience of 
chronically ill people with varying levels of patient activation.  
The second aim of this dissertation research partly addressed the theoretical gap in patient 
activation literature through novel application of a health outcome conceptual model to examine 
the concept. Specifically, the Revised Wilson Cleary Model (Ferrans et al., 2005) framed the 
examination of relationships among patient characteristics, health outcomes, and patient 
activation level of people with COPD. Further research is required to establish understanding of 
the complexities of patient activation for people with specific chronic conditions. 
The emerging literature that described determinants of patient activation level among 
people with chronic diseases illuminated relevant health factors and patient characteristics that 
could contribute to self-management risk assessment or intervention design. In the context of 
COPD, the results from the Dutch studies by Bos-Touwen et al. (2015) and Korpershoek et al. 
(2016) reflected predictive factors that were likely unique to the Netherlands’ health care system, 
lifestyle factors, and environmental characteristics. Though informative, these findings could not 
be generalized to adults in the U.S. with COPD. The diversity of determinants of patient 
activation identified in the literature review was difficult to contextualize within the predominant 
models of chronic disease care. Some determinants reflected modifiable targets for self-





health. Others represented non-modifiable characteristics—most applicable to self-management 
risk assessment, including high comorbidity, limited social support, and negative affect states. 
Without an organizing framework to provide context to these findings, it was impossible to 
translate these findings to the current chronic care paradigm.  
Findings from the third aim of this study begin to illuminate the independent patient and 
disease-specific predictors explaining the variance in patient activation level among U.S. adults 
living with COPD.  These factors have not been described in the extant patient activation 
literature. Further, these determinants contribute to call from the COPD self-management 
research community to identify the unique patient characteristics necessary to self-manage.  
Summary 
This chapter provided a review and synthesis of the relevant theoretical and research 
literature related to self-management of COPD and patient activation. Empirical evidence 
demonstrated a positive association between patient activation, self-management, and health 
outcomes in chronic disease. The significance of self-management to achievement of treatment 
goals in COPD, most notably quality of life, underscores the importance of exploring patient 
activation in the lives of people with COPD. Further, the research priority of the COPD 
community to understand the patient characteristics necessary to effectively self-manage 








 The objective of this quantitative study was to describe and examine the relationships 
among patient characteristics and health outcome factors, as conceptualized in the Revised 
Wilson Cleary Model (Ferrans et al., 2005), as determinants of patient activation in adults with 
chronic obstructive pulmonary disease (COPD). The specific aims of this study were to: (a) 
describe the patient characteristics (individual and environmental), health outcome factors 
(biological function, symptoms, functional status, general perception of health, and overall 
quality of life), and patient activation experienced by a cross-sectional sample of U.S. adults with 
COPD; (b) examine the unadjusted associations that patient characteristics and health outcome 
factors have with patient activation in the sample; and (c) identify the independent predictors of 
patient activation in the sample.  
This chapter presents the research design and procedures used in this dissertation study. 
A description of the participants, including the process of identification and recruitment of the 
study sample is offered. The measures, data management, and statistical procedures to achieve 
the study aims are presented. Finally, a discussion of ethical considerations to protect human 






 This cross-sectional, descriptive correlational study was designed to explore the 
determinants of patient activation level among patient characteristics and health outcome 
variables experienced by people living with COPD. A cross-sectional design was chosen to 
assess and describe the status of multiple phenomena experienced by people at a single point in 
time (Polit & Beck, 2012). The descriptive correlational design allowed for description and 
examination of the relationships among several study variables, not logistically or ethically 
conducive to manipulation, within a single group (Curtis, Comisky & Dempsey, 2016; Grove et 
al., 2013). Consistent with the method, measurement of variables was largely accomplished 
through collection of self-reported data with a questionnaire. As causality was not the goal of this 
inquiry, a non-experimental design supported the comprehensive examination of the 
determinants of patient activation, yielding new insight into the relationships among patient 
characteristics and the capacity to self-manage COPD. 
Population and Sample 
Population Description 
 The Centers for Disease Control and Prevention estimate the prevalence of COPD in the 
United States to be between 4% and 12%, varying significantly by geographical region, race, 
ethnicity, and socioeconomic status (CDC, 2017). The best current estimate of race and ethnic 
distribution of the disease in the U.S. suggests multiracial and American Indian or Alaskan 
Natives are mostly affected, followed by Caucasian non-Hispanics and much smaller numbers of 
African Americans, Latinos, and Asian Americans or Pacific Islanders (CDC, 2017; Tilert et al., 
2013). In addition, women now outnumber men diagnosed with COPD (CDC, 2017). COPD is a 





years of age and diagnosis after age 65 (CDC, 2017). The main cause of COPD in the United 
States continues to be tobacco smoking (NHLBI, 2013). Closely following cigarette smoking, 
environmental and occupational exposures, and childhood respiratory infections and genetics, 
which have been implicated as causal factors for COPD (GOLD, 2018). Recent statistics from 
the Centers for Disease Control suggest that COPD prevalence, morbidity requiring 
hospitalization, and death is significantly higher among people living in rural America than 
among those in urban areas (Croft et al., 2018). 
Sample Description 
 A purposeful sampling design was used to obtain participants for the study. This design 
reflected a desire for a representative sample of adults living with COPD in the United States 
with minimal sampling error and limited systematic bias (Grove et al., 2013). Inclusion criteria 
were men and women who: (a) were 40 years of age or older, (b) had a clinical diagnosis of 
COPD, chronic bronchitis, or emphysema, (c) had completed spirometry at the study site, (d) 
were current or past smokers of at least 10 pack-years, (e) had a U.S. primary mailing address, 
(f) could speak and read the English language, and (g) could provide informed consent for 
participation in this study. Exclusion criteria included persons: (a) living in an assisted living or 
skilled nursing facility, (b) enrolled in adult complex care coordination programming, (c) were 
prisoners, or (d) had diagnosed cognitive disease or mental illness impairing ability to answer 
questions or provide informed consent. 
 The inclusion and exclusion criteria defined for this study were chosen to identify a 
representative sample of adults with COPD living in the United States able to engage in self-
management activities. Participants were not excluded based on race or ethnicity. The age 





excess sputum production) do not typically present before the age of 40 years (NHLBI, 2013). 
No upper age threshold was set for the study. Pregnant women could participate as this survey 
study posed minimal risk. Finally, children were not eligible to participate because the trajectory 
of exposures and impairment of lung function associated with COPD impacts only adults.  
 A sample of American adults who received care at one of three major Mayo Clinic 
campuses in the United States was sought for the study. The Mayo Clinic provides general 
medical and specialty care for a predominately U.S. patient population, though draws an 
international clientele as a known healthcare leader in the world. The Mayo Clinic campuses, 
located in the American Southwest, Midwest, and Southeast, offer comprehensive pulmonary 
care, including pulmonary function testing and radiological testing, associated the diagnosis and 
treatment of COPD.  
Sampling Plan  
 The sample was obtained through use of Informatics for Integrating Biology and the 
Bedside (i2b2) supported by Grant Number UL1 TR002377 from the National Center for 
Advancing Translational Science. The i2b2 tool is a self-service, scalable informatics framework 
utilizing patient-oriented clinical data for various types and stages of research 
(https://www.i2b2.org). A i2b2 search query was developed based on searchable inclusion 
criteria of the study. The query, which included patient demographics, vital status, diagnoses, 
and spirometry procedures, yielded an adequate sample of 641 patients. After removing non-
English speaking and international patients, random numbers were assigned to the remaining 574 
patients of the accessible sample. The i2b2 output file was sorted in ascending order, using 
Microsoft Excel (Microsoft Office 365 Home 2016, Version 1804) functions to create a 





were reviewed for eligibility, including confirmation of COPD diagnosis and spirometry results, 
smoking history, indication of skilled care status, care coordination participation, and 
incarceration. A total of 250 eligible patients were approached via a mailed study packet. 
 Sample size. An a priori power analysis was conducted using G*Power 3 (G*Power 3 
for Windows 8, Release 3.1.9.2) software for multiple linear regression (Faul, Erdfelder, 
Buchner & Lang, 2009). With a significance level of .05, 80% power, estimate of six predictor 
variables, and a conservative medium effect size of f2 = 0.15, based on the work of Korpershoek 
et al. (2016), who reported a modest R2 of 0.17, 98 participants were required. To account for 
attrition or incomplete data in the survey methodology, 20% was added to the power analysis 
results, yielding in a desired total sample size of approximately 120 participants. 
 Two hundred and fifty patients identified from the i2b2 search were approached for 
participation through the study mailing, described in detail later in this chapter. Eighty-eight 
patients responded to the study mailing. Twenty-three patients declined participation and six 
patients approached were noted to be deceased via letter, telephone, or email message from a 
family member to the PI. Fifty-nine surveys were returned. Three of these surveys were not 
included in the data analysis, as the participants did not accompany them with signed consent. In 
addition, eight completed surveys were included from the pilot study, increasing the total sample 
size to 64. The pilot study is described in detail later in this chapter.  
Methods 
Instrumentation  
 The instruments used to measure the variables in this study are presented as organized 
by the domains of the Revised Wilson Cleary Model (Ferrans et al., 2005). Characteristics of the 





functional status, general perception of health, overall quality of life) were measured as 
independent variables by tools with good validity and reliability in the population. The 
dependent variable patient activation was adapted to be examined within the Revised Wilson 
Cleary Model (Ferrans et al., 2005) and was measured with the Patient Activation Measure.  
Characteristics of the Individual and the Environment 
 As defined by Ferrans et al. (2005), the collective characteristics of the individuals and 
their environment reflect the psychosocial, demographic, interpersonal, developmental, setting, 
and biological factors, which influence health and health outcomes of people living with chronic 
disease. For this study, psychological measures, specifically positive and negative affect, were 
measured by the Positive Affect Negative Affect Schedule (Watson, Clark & Tellegen, 1988). 
The demographic measures of age, gender, race, ethnicity, formal education, earned income 
level, and working status were assessed. Biological measures included the following self-
reported variables: (a) height and weight to calculate Body Mass Index , (b) health care 
utilization (i.e., number of visits to an emergency department due to breathing problems and 
number of visits to a primary care provider for breathing problems in the past 12 months), (c) 
smoking status and history (i.e., current or former smoker and total pack-years), and (d) time 
since diagnosis of COPD. Characteristics of the environment were assessed with the following 
independent variables: (a) category of residence (rural or urban), (b) marital status (single, 
married/committed relationship, separated/divorced, or widowed), and (c) living status (alone or 
with others).  
 Demographic form. Individual and environmental characteristic variables were 
assessed through self-reported responses on the demographic form. Age was reported in years, at 





Census Bureau Questionnaire categories (U.S. Department of Commerce, United States Census 
Bureau, 2013a). Marital status was identified based on six categories: married, civil 
union/domestic partnership, widowed, living with significant other, single (never married), and 
divorced/separated. The reported highest completed formal education program reflected 
educational level. Participants chose one of the following to reflect employment status: (a) 
currently working, (b) on leave of absence, (c) retired (not because of ill health), (d) disabled 
and/or retired because of ill health, (e) homemaker, and (f) unemployed to assess employment 
status, consistent with the 2013 United States Census Bureau Questionnaire categories (U.S. 
Department of Commerce, United States Census Bureau, 2013b). Self-report of total household 
income from all sources in the past year reflected their annual earned income (U.S. Department 
of Commerce, United States Census Bureau, 2016). The total number of years since diagnosis of 
COPD was captured through response to the choices of 0-3 years, 3-10 years, and greater than 10 
years, consistent with prior studies of determinants of patient activation in COPD (Korpershoek 
et al., 2016). Primary care and emergency department visits because of breathing problems in the 
past 12 months were recorded. Smoking history of participants was assessed by asking if they 
were: (a) current or former smokers (of cigarettes and/or pipes), (b) the average number of 
cigarettes/pipes smoked per day, while smoking, and (c) the total number of years as a smoker. 
These values were used to calculate smoking pack-years per the GOLD Guidelines (GOLD, 
2018).  
 Participant response to the question, “Who do you live with—alone or with family or 
friends?” reflected their current living status. The United States Census Bureau defines rural as 
what is not urban (Ratcliffe, Burd, Holder & Fields, 2016). Thus, congruent with the 2010 





community/outlying area of less than 50,000 residents (rural) or greater than 50,000 residents 
(urban) (U.S. Department of Commerce, United States Census Bureau, 2012). See Appendix E 
for the demographic form.   
 Positive and negative affect schedule (PANAS).  PANAS (Watson, Clark & Tellegen, 
1988) is a 20-item self-report measure designed to evaluate the extent individuals experience a 
range of positive and negative affect states. See Appendix A. Ten positive adjectives and 10 
negative adjectives are presented with respondent instructions to indicate how much each of the 
adjective items had been experienced, using a 5-point Likert scale (1 = very slightly, 5 = very 
much). As affect can be both a mood trait (dispositional) and a state concept (situational), the 
PANAS is robust in measuring both forms of affect by allowing investigators to choose the time 
frame to assess either (Merz & Roesch, 2011). For this study, the mood trait or dispositional 
nature of participant’s positive and negative affect was of interest and assessed by asking the 
participants to respond to items with the time period of “in the past month” (Watson, et al., 
1988).  
 Scoring and administration. Positive and negative affect scores (interval level data) 
were calculated by summing responses in each domain (Watson et al., 1988).  Scores in each 
domain can range from 10 to 50, with higher domain scores reflecting greater affect level. 
Responding to the 20 items of the paper-and-pencil test took approximately five minutes. 
PANAS is a publicly accessible tool, free for clinical and research use (Crawford & Henry, 
2004). 
 Psychometrics. Initial reliability and validity testing by Watson, Clark and Tellegen 
(1988) yielded correlation coefficients of .86 for the positive affect sub-domain and .87 negative 





examinations in healthy samples yielded fit indices of 0.94 and sub-domain correlation 
coefficients ranging from .80 to .92 (Crawford & Henry, 2004; Merz & Roesch, 2011). Further, 
Crawford and Henry (2004) reported minimal influence of demographic variables (i.e., age, 
gender, income level) on PANAS sub-domain scores, suggesting stability and reliability of the 
tool across demographic groups. Hu and Gruber (2008) reported excellent internal consistency 
values of α = .86 and .83 for the positive and negative affect subscales, respectively, in older 
adults with multiple chronic conditions, including COPD. In this dissertation study the 
Cronbach’s alpha for the total tool was .761 and the positive and negative affect subscales were 
.923 and .870, respectively. 
 PANAS is frequently cited in COPD outcomes research describing relationships 
between dyspnea and mood (Carrieri‐Kohlman et al., 2010) and affect and quality of life (Benzo 
et al., 2016) of those with the disease. The PANAS was appropriate for the goals of this study 
because of: (a) good to excellent reliability and validity of the PANAS in chronic disease studies, 
(b) established use in COPD research, and (c) simplicity of response by participants.  
Biological Function 
 Biological function represents the molecular, cellular, and whole organ system 
processes that support life and is operationalized through measures to assess and diagnose organ 
function (Ferrans et al., 2005). The gold standard for COPD diagnosis is the measurement of 
large and small airway obstruction in the lungs using spirometry (GOLD, 2018). Spirometry 
results, specifically the most recent post-bronchodilator forced expiratory volume (FEV1) value 
and ratio of forced expiratory volume (FEV1) to forced vital capacity volume (FVC), were 





 Spirometry. Spirometry is a physiological test to measure how an individual inhales 
and exhales volumes of air over a function of time (Miller et al., 2005). The standardized 
assessment yields objective measures of health or dysfunction of the lungs and airways. The 
American Thoracic Society and European Respiratory Society Task Force published a 
standardized spirometry guideline in 2005. The guideline outlines standards for equipment, 
technical factors, and age, gender, and race norms for outcomes (Miller et al., 2005). At the study 
site the guideline is used to obtain spirometric measures of forced expiratory volume (FEV1), the 
volume of air in the first second of forceful exhalation, and forced vital capacity (FVC), the 
largest volume of forcefully exhaled air following maximum inspiration. The ratio of these 
values reflects the degree of airway obstruction. A FEV1/FVC < 0.70 and FEV1 < 80% of the 
predicted value for age, gender, and race, are required elements for diagnosis of COPD (GOLD, 
2018). 
 COPD severity was categorized based on standardized spirometry criteria established 
by the Global Strategy for the Diagnosis, Management and Prevention of COPD (GOLD) 
(GOLD, 2018). GOLD classifies COPD in four stages: (a) COPD stage 1: mild (FEV1/FVC< 
0.70, FEV1 <80% predicted), (b) COPD stage 2: moderate (FEV1/FVC< 0.70, FEV1 50-80% 
predicted), (c) COPD stage 3: severe (FEV1/FVC< 0.70, FEV1 30-50% predicted), and (d) 
COPD stage 4: very severe (FEV1/FVC< 0.70, FEV1 <30% predicted) (GOLD, 2018). The FEV1 
and FEV1% predicted (continuous-level data) were abstracted from the medical record. The 
FEV1/FVC values of each participant were verified to meet the benchmark of < 0.70 for 






 Symptoms reflect the abnormal physical, emotional, or cognitive state experienced by 
persons with chronic disease (Ferrans et al., 2005). Perception of symptoms is a key patient 
outcome measure, as chronic diseases are managed, not cured (Redman, 2007). Dyspnea and 
fatigue are pervasive symptoms experienced by people with COPD. The negative impact of these 
symptoms on quality of life is the reason they are the primary foci of medical and self-
management interventions (Kaptein et al., 2014). The symptoms domain of the model was 
measured with the Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQ-
M) dyspnea and fatigue sub-scales (Lareau, Meek & Roos, 1998). Discussion of the PFSDQ-M 
psychometrics is presented in the following section, Functional Status. 
Functional Status 
 Ferrans et al. (2005) defined the concept of functional status as a person’s ability to 
perform tasks in multiple domains of his/her life, reflecting adequate physical, social, role and 
emotional capacity. In both clinical and empirical literature, the gold standard criterion for 
assessment of functional status in COPD is exercise capacity measured by a standardized 
exercise test (Monjazebi et al., 2016). Thus, an emphasis is placed on one’s physical capacity to 
carry out the task of walking, minimizing the multidimensional capacity needed to engage in the 
many facets of daily life. For this study, the robust Pulmonary Functional Status and Dyspnea 
Questionnaire-Modified (Lareau, Meek & Roos, 1998) was chosen to quantify the level of 
overall functional status. It addresses both the physiological impact of COPD (muscle weakness, 
limited energy capital, and decreased stamina) and the role-limiting effects of symptoms on 
engaging the basic activities of daily life. Consistent with Ferrans’ definition, this tool measures 





assesses walking activity and is thus congruent with the predominate emphasis on walking 
function in the COPD literature. 
Pulmonary functional status and dyspnea questionnaire-modified (PFSDQ-M). The 
Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQ-M) (Lareau et al., 
1998) is a disease specific, self-administered instrument designed to assess the change in ability 
to carry out common daily activities. The activities include bathing, dressing, walking, 
negotiating unlevel terrain and stairs, and preparing food, currently as compared to before the 
onset of the physiological and symptom impact of chronic lung disease. See the PFSDQ-M in 
Appendix B. This self-report tool of 40 questions is a modification from the original 167-
question Pulmonary Functional Status and Dyspnea Questionnaire (Lareau et al., 1998). This 
version includes activities common to most adults with breathing difficulties and has fewer 
questions, decreasing survey burden. The PFSDQ-M takes less than 10 minutes to complete and 
requires reading skills at the 6th-7th-grade level, consistent with reasonable literacy standards and 
time burden for questionnaire response (Creswell, 2014).  
Scoring. For each component, dyspnea, fatigue, and change in activities of living since 
diagnosis, ratings are noted on an 11-point Likert scale ranging from 0 to 10. For the symptom 
components qualifiers of “No shortness of breath/fatigue” equal to 0 and “Very severe shortness 
of breath/fatigue” equal to 10 are presented to orient responses. The change in activity 
component scales also have qualifiers, for example, “As active as I have ever been” on the 0 end 
of the scale to “Have omitted doing (the activity) entirely” on the 10 end of the scale. For each of 
the three components scores are calculated with sums ranging between 0 and 100, lower scores 
indicating better functional status or lower symptom impact. Further, sub-scale component 





The total score for the Dyspnea sub-scale and total score for the Fatigue sub-scale (ratio 
level data) represented the symptom domain measure of the Revised Wilson Cleary Model 
(Ferrans et al, 2005). The total score for the activity sub-scale provided a measure of overall 
functional status from the model.  
Psychometrics. Reliability of the PFSDQ-M was established through test-retest intraclass 
correlation coefficient of .93 (Kovelis et al., 2008). Internal consistency and convergent validity 
of the PFSDQ-M total score, dyspnea sub-score, fatigue sub-score, and change in activity sub-
score was supported by reported high Cronbach α of .93 to .95 when the instrument is tested 
against the St. Georges Respiratory Questionnaire, Medical Research Council Scale (Kovelis et 
al., 2008), and London Chest Activity of Daily Living Scale (Kovelis et al., 2011) in older adults 
(mean age > 65 years) with stable moderate to severe COPD. Further, as a measure of dyspnea, 
sensitivity of discrimination of dyspnea scores in people with mild to severe COPD was 
demonstrated through significant correlations with FEV1, FEV1 (% predicted), FVC (% 
predicted), FEV1/FVC and partial pressure of oxygen (Regueiro, et al., 2013). In this dissertation 
study, internal consistency was similarly high for the PFSDQ-M with a Cronbach’s α for the 
dyspnea sub score of .946, fatigue sub score of .940, and activity sub score of .943. 
General Health Perceptions 
 General perception of health is a uniquely perceived, multidimensional representation 
of an individual’s evaluation of their overall health status (Ferrans et al., 2005). Consistent with 
the recommendations of Ferrans et al. (2005), general perception of health was operationalized 
for this study by a single question from the general perception of health domain within the 





 Single question from medical outcomes study SF-36. The global question from the 
Medical Outcomes Study SF-36 assessed general perception of health by asking, “In general, 
would you say your health is: excellent, very good, good, fair or poor?” (Ware & Sherbourne, 
1992). See Appendix D. Use of the single question within clinical or research settings for 
assessment of self-rated health assessment does not require license for use (Ware & Sherbourne, 
1992). 
 Scoring. Respondents chose from one of the five levels to answer the question: 
excellent (5), very good (4), good (3), fair (2), or poor (1). Responses were dichotomized 
(nominal level data) and coded with 0 for those choosing “very/good” or “excellent” and 1 for 
“fair” or “poor” respectively, in accordance with previous studies (Nguyen et al., 2008). The 
single question is accessible in the public domain and requires only seconds to respond to when 
included in survey tools (Wagner & Short, 2014). 
Psychometrics. Internal consistency of this single question from the SF-36 to measure 
general perception of health in people with chronic disease, including COPD, has been reported 
with Cronbach’s alpha of .78-.93 (Brazier et al., 1992; Wagner & Short, 2014; Ware & 
Sherbourne, 1992). Convergent validity established by correlations between this question and 
other measures of general perception of health has been reported with the General Health Rating 
Index r = .96 (Ware & Sherbourne, 1992) and the Nottingham Health Profile, r = .87 (Brazier et 
al., 1992). Internal consistency was not calculated for this single item within this dissertation 
study. 
Overall Quality of Life 
 Overall quality of life is characterized as the subjective, multidimensional measure of 





quality of life anchors the Revised Wilson and Cleary Model of Health-related Quality of Life 
(Ferrans et al., 2005) as the most complex health outcome, reflecting integration of all health 
outcomes and patient characteristics preceding it. In 1990 Ferrans published a conceptual 
framework of quality of life that described the domains of health and functioning, social and 
economic, psychological and spiritual, and family as integral to overall quality of life. Ferrans et 
al. (2005) applied these domains to clarify and expand the conceptual definitions of 
characteristics of the individual and characteristics of the environment in their revision of the 
Wilson and Cleary Model. The disease-specific version of the Quality of Life Index-Pulmonary 
Version III (Ferrans & Powers, 1985) was chosen to provide a conceptually grounded measure of 
the health outcome overall quality of life in this study. This tool presents a structure of assessing 
overall quality of life congruent with Ferrans’ conceptual definition of quality of life, “a person’s 
sense of well-being that stems from satisfaction or dissatisfaction with the areas of life that are 
important to him/her” (Ferrans, 1990, p. 15). 
 Quality of life index-pulmonary version III (QLI-P). The QLI-P (Ferrans & Powers, 
1985) is a self-report instrument comprised of 36-paired questions assessing personal satisfaction 
and importance of various aspects of life. Importance ratings are used to weight satisfaction 
responses so that the scores reflect the respondent’s satisfaction with the aspects of life they 
value the most (Ferrans & Powers, 1985). This instrument assesses importance and satisfaction 
within four life domains to provide an objective measure of overall quality of life. A common set 
of life items form the basis of the tool, with pulmonary-specific items inquiring about symptom 
(e.g., dyspnea, coughing, fatigue) impact on life. Respondents chose the degree of satisfaction 





1 meaning “very dissatisfied/unimportant,” and 6 meaning “very satisfied/important.” See 
Appendix C for the QLI-P. 
 Scoring and administration. The possible range for the total quality of life score is 0 to 
30, with higher scores indicating a higher overall quality of life. While sub-scale scores for each 
domain could be calculated, the total score was used to operationalize overall quality of life for 
analyses. The instrument is written at the fourth-grade reading level (Ferrans & Powers, 1985) 
and was free to use for non-profit research (qli.org.uic.edu, n.d.). 
Psychometrics. Internal consistency reliability for the QLI total score across adult age 
groups (Ferrans & Powers, 1985; Nesbitt & Heidrich, 2000), healthy subjects (Ferrans & 
Powers, 1985; Scott, 2000) and those with chronic diseases (Ozer & Efe, 2006; Scott et al., 
2004), has been supported by Cronbach’s alphas ranging from .89 to .93. Extensive empirical 
literature review of factors related to quality of life generated the common and disease-specific 
questionnaire items and established the content validity of the QLI and QLI-P (qli.org.uic.edu, 
n.d.). Construct validity of the QLI is supported by strong correlations between the total score 
and life satisfaction (r = .93) (Ferrans & Powers, 1985, 1992) and factor analysis of each of the 
four domains explaining 91% of the total variance of quality of life (Ferrans & Powers, 1992). A 
limitation of this tool was the lack of reliability and validity reporting among adults with COPD. 
For this dissertation study, the Cronbach’s alpha of the QLI-P total score was high at .908. 
Patient Activation Level 
Patient activation is a measure of self-management capacity, operationally defined as the 
belief an individual has an important role to play in their health, demonstrated through the 
knowledge, skills, and confidence to maintain function, response to health changes, and access 





(PAM) (Hibbard, et al., 2004) objectively characterizes an individual’s activation level on a 
spectrum of passive care receiver with limited self-management capacity (Level 1) to confident, 
capable, and engaged self-manager (Level 4) (Hibbard et al., 2004). Patient activation was 
operationalized for this study by the Patient Activation Measure-13 (Hibbard et al., 2005). Due 
to copyright restrictions, the PAM-13 is not included in the appendices. 
 Patient activation measure-13.  PAM-13 is an interval-level, unidimensional, 
Guttman-like scale assessing an individual’s knowledge, skills, and confidence for self-
management in chronic disease. This tool was developed and tested by Hibbard and colleagues 
(Hibbard, Stockard et al., 2004; Hibbard, Mahoney et al., 2005). The PAM aims to assess 
cognitive and psychological variables through patient self-report of agreement or disagreement 
with 13 escalating statements on confidence, skills, beliefs, and knowledge related to personal 
health maintenance (Hibbard et al., 2004).  
 Scoring. The PAM-13 was administered as a self-report, paper-and-pencil questionnaire 
and took approximately 10 minutes to complete. Responses fall on a 4-point Likert scale 
(disagree strongly to agree strongly). Summation of responses generated a raw score that was 
converted to a continuous activation score (ranging from 0-100) (Hibbard et al., 2004). Further, 
scores were grouped into four hierarchal levels of health activation: (a) PAM level 1 (≤ 47.0,) 
reflects an overwhelmed, passive recipient of care, (b) PAM level 2 (47.1 – 55.1) represents a 
lack of knowledge and necessary confidence to engage in self-management, (c) PAM level 3 
(55.2 – 67.0) shows an individual beginning to engage, but needs support to learn new skills and 
maintain behaviors, and (d) PAM level 4 (≥ 67.1) reflects an active self-manager who may need 
support in times of stress (Hibbard et al., 2004). The PAM-13 was licensed for this dissertation 





Psychometrics. Numerous research studies across diverse health populations and adult 
ages have shown PAM-13to be valid and reliable (Fowles et al., 2009; Hibbard et al., 2015; 
Hibbard & Tusler, 2007; Skolasky et al., 2011). In development and testing of a measure of 
patient activation, Rasch person reliability was satisfactory at .85 (Grove et al., 2013; Hibbard, 
Stockard et al., 2004; Hibbard, Mahoney et al., 2005). Good internal consistency of the 22-item 
and 13-item versions of the PAM was reflected by a Cronbach’s alpha of .87 (Hibbard, Stockard 
et al., 2004; Hibbard, Mahoney et al., 2005). Content validity of the PAM to adequately measure 
the complex construct activation was established through an expert panel, reflecting diverse 
utilization of health activation in human functioning, consensus followed by patient focus group 
consensus for final item content and development of a conceptual activation definition (Hibbard 
et al., 2004).  
 Skolasky et al. (2011) explored increased age and multimorbidity among community-
dwelling older adults within a group health organization to examine the construct validity of 
PAM for clinical use. Consistent with Hibbard et al. (Hibbard, Stockard et al., 2004; Hibbard, 
Mahoney et al., 2005), Skolasky and colleagues found high internal consistency of the items on 
the PAM-13 with a Cronbach’s alpha of .87 in the subgroups examined. Fowles et al. (2009) 
further validated the PAM in a randomized trial of two health promotion programs within a large 
midwestern health maintenance organization. The study population reflected a diverse 
demographic sample of adults in two different work environments with varied health risk factors 
and health status. Rasch person reliability for each group was .83 and high internal consistency 
was noted with a Cronbach’s alpha of .90 (Fowles et al., 2009). Lower item reliability was noted 
in the no chronic disease, age greater than 85 years, lower socio-economic status, and low self-





shown the internal consistency of PAM-13 items to be valid and reliable (Hibbard & Mahoney, 
2010; Skolasky et al., 2011). In this dissertation study, the Cronbach’s alpha for the PAM-13 was 
.893, consistent and slightly higher than the original work of Hibbard and colleagues in 2005. A 
summary table organizing the research variables as presented in the Revised Wilson Cleary 
conceptual model is presented in Figure 3.   
Model Domain: Biological Factors 
Independent Variables Instrument/Measure Level of Measurement 
Lung function Spirometry results (FEV1 and FEV1% Predicted) 
 




Model Domain: Symptoms 





Pulmonary Functional Status and Dyspnea  
Questionnaire: Dyspnea subscale score 
 
Pulmonary Functional Status and Dyspnea 





Model Domain: Functional Status 
Independent Variables Instrument/Measure Level of Measurement 
Functional status Pulmonary Functional Status and Dyspnea 
Questionnaire: Total Score 
Ratio 
Model Domain: General Perception of Health 
Independent Variables Instrument/Measure Level of Measurement 
General perception of health Single question of self-rated health from Medical 
Outcomes Study SF-36 
Ordinal 
Model Domain: Overall Quality of Life 
Independent Variables Instrument/Measure Level of Measurement 
Overall quality of life Quality of Life Index- Pulmonary Version III Ratio 
Model Domain: Individual Characteristics 
Independent Variables Instrument/Measure Level of Measurement 
Age, gender, race, ethnicity, 
educational level, earned 
income level, employment 
 
Affect (Positive and Negative) 
 
Health care utilization 
 
Smoking history (current or 
former smoker, pack-years) 
 
Height and weight 
 
 












*Body Mass Index (BMI) calculated from self-reported 
height and weight 
 
*Duration of COPD reflected self-reported total number 


















Figure 3. Research Variable Table. Adapted from the Revised Wilson Cleary Model  







Figure 3. cont. 
Model Domain: Environmental Characteristics 
Independent Variables Instrument/Measure Level of Measurement 
Living situation (alone or with 
others), residence (rural vs. 













Additional Model Domain: Patient Activation Level 
Dependent Variable Measure Level of Measurement 
Patient Activation Patient Activation Measure-13 Ratio 
 
 
Figure 3. Research Variable Table. Adapted from the Revised Wilson Cleary Model  
(Ferrans et al., 2005). 
 
Pilot Study 
 Prior to implementing the survey study at Mayo Clinic, a pilot study was conducted to 
assess clarity of the questionnaire developed for data collection and the time needed to complete 
the tool. The University of North Dakota Institutional Review Board (IRB) and the American 
Lung Association Better Breather’s Clubs of the Twin Cities (ALAMN-BBC) provided ethical 
and conduct approval of the pilot study. The principal investigator (PI) introduced the study at 
the end of a regularly scheduled ALAMN-BBC meeting and the twelve attending members were 
invited to participate in the anonymous survey. An IRB-approved Informed Consent Statement, 
survey, and a postage-paid return envelope were provided to a convenience sample of nine 
attendees who expressed interest in participating. The survey tool included three additional 
questions to assess clarity of specific questions, format of the survey tool, and the total time 
spent to complete the questionnaire. Eight people returned completed surveys. Based on their 
responses, small changes were made to the format to improve readability and clarity of the 





spirometry results, specifically FEV1 and FEV1 percent predicted, was difficult and would lead to 
high missingness in the data. Only three participants were able to self-report one of two 
necessary spirometry values to assess degree of obstruction and disease severity. As central 
variables to examine biological function within the conceptual model and common elements in 
COPD research to meaningfully describe disease severity of study samples, it was necessary to 
identify another way to obtain spirometry data. Therefore, the decision was made to partner with 
healthcare organization for participant recruitment and data collection of spirometry values for 
the study.   
Data Collection 
 The primary data collection method was participant completion of a self-report 
questionnaire. Questionnaires are a direct, cost-effective method of collecting self-report data 
from a geographically dispersed sample (Waltz et al., 2010). Standardization within a 
questionnaire format and ability to answer questions in the privacy of one’s own home, “supports 
increased reliability of responses, facilitates comparison across respondents, and removes 
interviewer bias as a threat to validity” (Waltz et al., 2010, p. 308). The study questionnaire 
included the instruments described previously: (a) demographic form, (b) Pulmonary Functional 
Status and Dyspnea Questionnaire-Modified, (d) single question from the Medical Outcomes 
Study Short-form 36 to assess self-rated health, (e) Quality of Life Index-Pulmonary Version III, 
and (f) Patient Activation Measure-13. Data from the pilot study suggested the 160-item 
questionnaire took approximately 25 minutes to complete. Additionally, the most recent 
spirometry results were abstracted from the medical record.  
 Based on the principal investigator’s prior survey research experience of older adults 





participants. Instructions for questionnaire completion, including the option to contact the study 
team for telephone administration of the questionnaire, were included in the study introduction 
letter. It was expected that participants with visual impairments or low literacy requesting to 
complete questions over the telephone would be a rare occurrence and represent a small 
percentage of the data collected. Only one participant requested to complete the questionnaire by 
telephone.  
Survey Methodology 
 The three-phase, Dillman Total Design Method (Dillman, 1978; Dillman et al., 2014) of 
survey research was employed to achieve an optimal survey return rate for this study. The 
Dillman Method proposes an 80% return rate for survey research (Dillman et al., 2014). With all 
factors held constant, the higher the response to a survey, the more likely the data will be 
representative of the population that was sampled (Grove et al., 2013). The step-wise Dillman 
Method begins with an initial mailing of a detailed introductory letter explaining the purpose of 
the study, a questionnaire printed in booklet style, and a postage-paid return envelope. All 
written communication to patients was formatted in a positive, appreciative tone using plain 
language and was IRB approved. Please see the Ethical Considerations section below for detail 
regarding the review process for the study documents. The contact letter clearly described the 
purpose of the study and was signed by the principal investigator by hand, in blue ink (Dillman, 
1978). The questionnaire was formatted in booklet style with an illustrated front cover, included 
detailed instructions for completing the questions, and a unique respondent identifier (Dillman, 
1978).  
A pre-set pattern established the follow-up plan. Three weeks after the initial mailing 





study mailing was reissued to non-responders. Undeliverable paper questionnaires underwent 
address recheck for transcription error. The method frames the data collection process to a two-
month period. The 250 study mailings were divided into 3 groups with the first sent in November 
of 2017, second in January of 2018, and final sent in February of 2018. The pattern described by 
Dillman (1978) was followed, yielding total time of data collection for each of the groups to 2 
months. 
 Data management. Upon receipt of a completed questionnaire and signed Health 
Insurance Portability and Accountability Act of 1996 (HIPAA) authorization, the medical record 
was accessed for abstraction of the patient’s most recent spirometry results. Participant 
questionnaire responses and spirometry data were entered into the Statistical Package for Social 
Sciences (SPSS) software (SPSS for Windows, Version 25). Accuracy of the final dataset was 
established through crosschecking of every fifth participant’s questionnaire and spirometry 
report against the data file in SPSS. 
Ethical Considerations 
The study protocol was reviewed and approved by the Mayo Clinic and the University of 
North Dakota Institutional Review Board. The Mayo Clinic served as IRB of Record and the 
University of North Dakota served as Relying Organization for the ethical and regulatory 
oversight of the study. This study posed minimal risk to participants involving the use of a 
survey and abstraction of limited protected health information from the patient’s medical record. 
All documents within the study mailing were Institutional Review Board approved. Please see 
Appendices H-J for the study contact letter, Health Insurance Portability and Accountability Act 
of 1996 (HIPAA) authorization, questionnaire, and reminder postcard. Contact letters sent to the 





voluntary, minimal risk nature of the study, (b) explained the expected benefits, (c) explained the 
right of participants to not answer any questions in the survey that made them uncomfortable, 
withdraw from the study at any time, or decline participation, (d) provided opportunity to request 
to participate in the study by telephone, and (e) provided contact information for the study team 
to ask questions about the research. The Health Insurance Portability and Accountability Act of 
1996 authorizations (see Appendix J) were used to obtain informed consent for abstraction of 
limited protected health information, specifically spirometry results, from participants’ medical 
records. All study personnel completed human subject protection training prior to initiation of 
the study. 
Confidentiality and Data Security 
 All patient information and participant data were handled in a confidential manner. 
Confidentiality of the electronic dataset, comprised of entered questionnaire responses and 
spirometry results, was maintained using unique alphanumeric codes assigned to each study 
participant. Only the PI had access to the linking file, which associated patient identifiers with 
study identifiers. Further, data were secured through password protection of the electronic 
dataset and i2b2 output stored on a dedicated research computer server at the study site. 
Completed hard-copy questionnaires, signed HIPAA authorizations, and printed spirometry 
reports were kept in a locked file cabinet at the researcher’s office at the study site, with access 
limited to the researcher and her site mentor. Participant data reported in this dissertation has 
been completed in aggregate to protect the anonymity of all participants involved in the study.  
Data Analysis  
Instrument scoring and psychometric testing was done prior to data analysis. The dataset 





assumptions of the univariate and multivariate analyses planned. All data analyses were 
conducted using the Statistical Package for the Social Sciences (SPSS for Windows, Version 25). 
Statistical significance (two-tailed) for data analysis was set at p < 0.05. The statistical consultant 
for this inquiry was included throughout database development, data preparation, and statistical 
analysis. Engaging the statistician throughout the research process ensured that the final data 
product was appropriate for analysis (Creswell, 2014). 
Missing Data  
 Missing data is the single greatest threat to validity in survey research design (Creswell, 
2014). Participants may have purposefully or inadvertently skipped or left questions blank within 
the study questionnaire. Frequencies were conducted to identify the extent of missing or 
unexpected values within the dataset. The amount and pattern of missing data, type of variable 
with missingness, and plan for handling the missing data is described. 
One or more questions not answered within a multi-question tool were described as item 
nonresponse (Patrician, 2002). All questions missed in a multi-question tool or nonresponse to a 
single question variable measure was considered variable or unit nonresponse (Fox-Wasylyshyn 
& El-Masri, 2005; Patrician, 2002). Variable and unit nonresponse poses greater threat to losing 
statistical power through deletion of cases and introducing nonresponse bias to the data. Neither 
variable or unit nonresponse was found in the dataset.  
The pattern of missing data points was established to identify the best approach to 
handling missing data (Shafer & Graham, 2002). Data missing at random (MAR) are values of 
data dependent upon other variables in the dataset (Allison, 2000). Data missing completely at 
random (MCAR) are values of data unique to the specific item and not related to other variables 





based on the type and pattern of missingness found, including sample mean substitution, case 
mean substitution, or hot-deck imputation. These processes could be utilized to impute best-
fitting values from specific items or variables within the dataset (Fox-Wasylyshyn & El-Masri, 
2005). Multiple imputation was also considered as a predictive technique utilizing iterative 
regression models to create “plausible imputations of missing values, to accurately reflect 
uncertainty, preserving important data relationships and aspects of the data distribution” 
(Patrician, 2002, p. 79). As it is difficult, if not impossible, to determine the mechanism of 
nonresponse in questionnaires, the advantages of multiple imputation’s ability to reflect 
uncertainty in missing data through incorporation of random error in the imputation process, may 
support use of the technique in addressing missingness for this analysis (Fox-Wasylyshyn & El-
Masri, 2005; Patrician, 2002). 
Overall, item and variable missingness was very low in the data set. For this dataset, the 
most appropriate single imputation technique to manage item missingness was case mean 
substitution. This method assumes that within an individual participant, known as a case, the 
item responses within a single tool or measure are closely related (Fox-Wasylyshyn & El-Masri, 
2005). Item missingness was identified in responses for the PAM-13, PANAS, PFSDQ-M, and 
QLI-P, though insignificant at less than 5%. Per the scoring instructions for the PAM-13 (13 
single question responses), case mean substitution was used to impute the data for missing values 
in among three cases for the dependent variable patient activation. Similarly, for missing case 
responses in the independent variables obtained from the PANAS (20 single question responses, 
10 per subscale), PFSDQ-M (30 single questions, 10 per subscale), and the QLI-P (72 single 
questions), a mean for the subscale scores within each missing case was obtained and imputed 





Variable missingness was also low. Single datum was missing for the variables years of 
education, visits to a primary or pulmonary doctor, emergency department visits, Body Mass 
Index. Two data were missing from the variable smoking pack-years. The degree of missingness 
among these variables was insignificant at less than 5%, suggesting the pattern of missingness 
was random (Schafer & Graham, 2002). However, five data were missing for the key the 
spirometry variable measuring biological function, FEV1, which was statistically significant (n = 
5, 8%, t = -10.914, p < .001) indicating the data were missing not at random. It was important to 
carefully consider how to manage the data missing not at random to avoid invalidating the results 
(Fox-Wasylyshyn & El-Masri, 2005). In this study, the spirometry variable missingness was 
explained through the inclusion of pilot study participants, five of which who were unable to 
access their spirometry results, as described previously in the pilot study section of this chapter. 
Through significant, consideration was given to the reason for missingness, desire to maintain 
sample size, and likelihood that pilot participants were more similar than different to participants 
identified from the study site. The decision was made to not exclude these cases and to utilize 
sample mean substitution to manage the variable missingness. See Table 2 for the frequency and 
handling procedures of missingness for these variables. 
Table 2. Variable Missingness and Handling Procedure 
Variable % Missing Handling Procedure 
FEV1
*  n = 5 (8%) Sample Mean Substitution (M = 1.30) 
Years of Education n = 1 (3%) Sample Mean Substitution (M = 3.5) 
Pack years (smoking) n = 2 (3%) Sample Mean Substitution (M = 46) 
MD visits n = 1 (3%) Sample Mean Substitution (M = 2) 
ED Visits n = 1 (3%) Sample Mean Substitution (M = 1) 
Body Mass Index n = 1 (3%) Sample Mean Substitution (M = 31) 
Note: N = 64  
*Though statistically significant, the pattern of missingness is explained by the inclusion of pilot 






Outliers and Normality of Distribution 
 The dataset was evaluated for outlier cases by examining all continuous variables as 
standardized scores. Outliers are extreme scores, which can cause skewness violating the 
univariate assumption of normality of a variable’s distribution (Tabachnick & Fidell, 2013). 
Single outlier scores were noted in the variables of FEV1, negative affect sub score of the 
PANAS, fatigue symptom sub score of the PFSDQ-M, and Body Mass Index; two outlier scores 
found in the variable emergency department visits. Though the extreme cases were from the 
intended population, the variability of these values led to significant skewness and kurtosis of the 
variable distribution. Sample mean substitution was utilized to correct the extreme scores and 
maintain sample size. 
Next, attention was paid to the distribution of the variables across the normal curve. In 
addition to visualizing the data in relation to their histograms, mathematical processes were 
applied to assess for skewness and kurtosis. Fisher’s skewness coefficient was calculated for 
each continuous variable and evaluated against the critical value for a two-tailed standardized 
score. Fisher’s coefficients greater than ± 3.26 were significantly skewed or kurtosed. Physician 
visits and emergency department visits demonstrated significant skewness and kurtosis. In 
addition, skewness was evident in the variables FEV1, negative affect sub score, dyspnea sub 
score, fatigue sub score, and activity sub score. The level of skewness in these variables seemed 
to be inherent to the population, reflecting the unique impact of the disease on the individual 
living with COPD. To manage the skewness and kurtosis consideration was given to log 
transformation or categorization of the continuous variables. Several variables were not 





successfully transformed via base-log arithmetic processes. Categorization of the skewed 
variables was rejected due to concerns regarding the small sample size of the study. If these 
variables were categorized and were found to be significantly associated with patient activation 
in the univariate analysis, they would require dummy variable creation for the multivariate 
regression. High numbers of dummy variables entered in linear regression analysis could make 
the resulting models unstable, raising questions regarding validity of the results (M. El-Masri, 
personal communication, April 25, 3018). Therefore, the decision was made to dichotomize the 
non-normally distributed variables. This was accomplished based on conceptual cut-off points 
congruent with each variable. 
Data Analysis Description 
 Descriptive statistics were performed for each measured variable. Means, medians, 
modes, ranges, standard deviations, and frequency distributions were calculated and reported in 
tabular format. See Table 3. Significance for all data analyses was established by a two-tailed 
alpha of .05. A three-step statistical analysis process, outlined by the three study aims, is 
described below.  
Specific aim #1. Describe the patient characteristics (individual and environmental), 
health outcome factors (biological function, symptoms, functional status, general perception of 
health, and overall quality of life), and patient activation experienced by a cross-sectional sample 
of adults in the United States with COPD. To describe the patient characteristics of the sample, 
means and standard deviations were calculated for the continuous variables. These included 
earned income level, health care utilization, smoking pack years, Body Mass Index, positive 
affect and negative affect sub scores calculated from the PANAS, PFSDQ-M dyspnea, fatigue, 





activation score. Frequencies and percentages were calculated for the nominal and ordinal 
variables of age category, gender, race, ethnicity, educational level, working status, smoking 
history, living status, community size, duration of COPD diagnosis, and the single question from 
the Medical Outcomes Study SF-36assessing general perception of health. Additionally, 
frequencies and percentages were calculated for the transformed variables that were 
dichotomized due to being non-normally distributed or containing greater than three levels of 
response.  
Specific aim #2.  Examine the unadjusted associations that patient characteristics and 
health outcome factors have with patient activation in the sample. Univariate correlation 
statistics, specifically a series of Pearson correlation coefficient (r) calculations for continuous 
variables and one-way ANOVAs for categorical variables, were conducted to examine the 
presence, strength, and direction of relationships among each of the patient characteristics and 
the health outcomes as independent variables, and the outcome variable patient activation. 
Statistical significance for these tests was set at a liberal α of 0.25 (i.e., p value of ≤ .25). Due to 
concerns regarding the small sample size, any categorical candidate variables (those with p value 
of ≤ .25) with greater than three categories would be dichotomized, based on their frequency 
analysis, for entry into the subsequent multivariate regression analysis. One-way ANOVAs 
would be repeated to assess if the dichotomized variables retained significant association with 
the outcome variable. 
Careful consideration was paid to two variables that raised concerns of conceptual 
confounding. Positive affect and negative affect are two concepts that are inversely related and 
as variables, posed risk of bivariate collinearity. If a participant had high positive affect, it would 





expected direction of the other. To address this concern, Kendal tau correlation coefficient was 
calculated using the non-normally distributed negative affect variable with positive affect. The 
result confirmed that negative affect has a non-statistically significant, negative association with 
positive affect (τ = -.42, p = .636). In addition, log transformed negative affect was entered into a 
Pearson correlation coefficient calculation with positive affect, similarly resulting in a non-
statistically significant, negative association (r = -.036, p = .780). Secondary to this analysis, the 
decision was made to only evaluate the positive affect variable in univariate and multivariate 
analysis to prevent potential confounding due to multicollinearity between positive and negative 
affect with patient activation. 
Specific aim #3. Identify the independent predictors of patient activation in the sample. 
Stepwise linear regression analysis was performed to identify the independent predictors of 
patient activation. To minimize the potential of model inflation and to ensure a parsimonious 
model, only independent variables whose univariate test had a significant association with 
patient activation at alpha of 0.25 were included in the multivariate regression analysis (Hosmer 
& Lemeshow, 2001). The percentage of variance explained by the remaining independent 
variables (R2 x 100) was calculated and reported. Higher percentages suggest the significant 
relationships among the variables were true determinants of patient activation (Grove, 2007).  
Several assumptions were verified to assure validity of the parametric linear regression 
analyses completed to meet Aim #3. Assumptions of linearity, normal distribution, and 
homoscedasticity were checked. Additionally, multivariate outliers and multicollinearity were 
considered among the significant univariate patient characteristics and health outcome variables 
entered into the regression model with patient activation (Grove, 2007). First, the relationships 





the dependent variable patient activation, was normally distributed overall and for each of the 
independent variables (Kellar & Kelvin, 2013). Third, the distribution of patient activation scores 
was approximately equally distributed for each independent variable, thus meeting the 
assumption of homoscedasticity (Grove, 2007).  
Multicollinearity, or high intercorrelation among the independent variables, is a 
significant threat in assessing complex, multidimensional health outcome variables (Curtis et al., 
2016). To meet this assumption, tolerance levels and variance inflation factors were calculated 
for each independent variable to identify multicollinearity when all the variables are examined 
together. The higher the tolerance value, the less likely collinearity exists among the variables 
(Kellar & Kelvin, 2013). The variance inflation factor reflects how much of R2 is inflated by 
multicollinearity (Mertler & Vannatta, 2002). Therefore, a tolerance value of less than .50 and a 
variance inflation factor greater than ten were used to identify multicollinearity of variables that 
required elimination from the regression models (Mertler & Vannatta, 2002). Condition indices 
that reflect the dependency of one variable on another in regression, were examined for values 
greater than 15 suggestive of collinearity and values greater than 30 indicatives of significant 
collinearity (Kellar & Kelvin, 2013). 
Finally, exploration for the presence and influence of multivariate outliers was 
conducted. Multivariate outliers may exist between two or more variables or items among 
variables that when combined can raise or lower the variance explained by the predictor 
variables identified in linear regression (Kellar & Kelvin, 2013). Mahalanobis distance was 
calculated for each case to identify the presence of multivariate outliers then assessed for 
significance utilizing the χ2 distribution, degrees of freedom equal to the number of independent 





an outlier influenced the estimate variance explained by R2. A threshold of one was set for 
Cook’s distance, values less than one, indicating the case was influential and should be deleted 
from the analysis.  
Limitations 
 Careful consideration was given to the design of this study, including identification of 
potential challenges and limitations. The following subsections explain the limitations of self-
report measures, selection bias, and the processes undertaken to minimize impact of these on the 
conduct and analysis of the study.  
Self-Report  
Self-reported measurement tools can pose inherent limitations on conceptual measures as 
they cannot be objectively verified (Lorig & Holman, 2003; Wilson & Cleary, 1995). 
Respondents may have over or under reported the significance of symptoms or perceptions of 
health, suffer from recall bias, or chose answers based on perceived social desirability when 
responding to the study questionnaire (Frank-Stromborg & Olsen, 2004; Grove, 2007). 
Nevertheless, the health outcome factors central to this study are personally experienced 
behavioral constructs (Ferrans et al., 2005). Wilson and Cleary (1995) acknowledged the 
measurement challenges of these factors and asserted self-report was necessary to obtain the 
lived perspective of the health outcomes within their model. The self-report measures chosen for 
this study were validated in in adults with chronic disease, which contributed to the internal 
validity of the study. 
Selection Bias 
 Selection bias and representativeness of the sample are concerns with survey 





academic medical center with clinical sites in the Midwest, Southeast, and Southwest United 
States. People who received health care, specifically pulmonary care, at the study site may have 
different care and self-management experiences than other people living with COPD across the 
county. Survey research carries with it unique concerns regarding selection bias. Characteristics 
of patients agreeing to be part of this study, as opposed to those who declined or did not respond, 
are difficult to predict and may not adequately reflect the U.S. population of adults with COPD. 
Participants drawn from a study site with an internationally known research reputation may have 
been more interested in research in general, the study topic, or more activated than people from 
the general population (Hibbard et al., 2015). The primary objective of the study was to gain 
knowledge, not infer causality for generalization to the adult COPD population, thus drawing a 
sample from a large, national health care organization was appropriate for sampling in this cross-
sectional, descriptive correlational design.  
 Language barrier. Inclusion of only adults who could read and speak English added an 
additional limitation associated with selection bias. The resulting sample was not entirely 
representative of the target population and further limits generalization of the results. 
 Homogeneity. Several individual characteristics and health outcome responses were 
homogeneous across the study sample. The differences in these factors between participants and 
patients who chose not to participate are unknown. Additionally, though the demographics of the 
study sample were consistent with many adults with COPD in the U.S., the lack of racial and 
ethnic diversity in the study sample further limits the generalizability of the results.   
Summary 
 This chapter provided a detailed explanation of the methods and procedures followed to 





and study setting were described. Next, sampling and recruitment plans described how the 
accessible sample was identified and obtained within the context of the larger population of 
interest. The sample size calculation to establish statistical significance in the subsequent data 
analyses was presented. The validity and reliability of the measurement tools, which comprised 
the study questionnaire and used to quantify the study variables derived from the Revised Wilson 
Clear Model (Ferrans et al., 2005), were presented. The data collection plan, guided by the 
Dillman Method (Dillman, 1978), data management processes to establish a complete, 
analyzable dataset, and efforts to protect human subjects and their protected health information 
were described. The chapter concluded with the data analysis plan used to address each of the 








 The purpose of this study was to describe and examine the relationships among patient 
characteristics and health outcome factors, as conceptualized in the Revised Wilson Cleary 
Model (Ferrans et al., 2005), as determinants of patient activation in adults with COPD. The 
specific aims of the study were to:  
1. Describe the patient characteristics (individual and environmental), health outcome 
factors (biological function, symptoms, functional status, general perception of health, 
and overall quality of life), and patient activation experienced by a cross-sectional sample 
of adults in the United States with COPD. 
2. Examine the unadjusted associations that patient characteristics and health outcome 
factors have with patient activation in the sample. 
3. Identify the independent predictors of patient activation in the sample. 
This chapter presents the results of this dissertation study including the characteristics of the 
sample from which the data were derived, the descriptive and inferential statistical analyses to 





Analysis of Specific Aims 
Specific Aim #1  
 The first aim of this dissertation study was to describe the patient characteristics, health 
outcome factors, and patient activation experienced by a cross-sectional sample of adults in the 
United States with COPD. Organized by the Revised Wilson Cleary Model (Ferrans et al., 2005), 
the patient characteristics were examined in the context of characteristics of the individuals and 
their environment. The health outcome factors were comprised of the biological function, 
symptoms, functional status, general health perceptions, and overall quality of life domains. The 
descriptive data representing the characteristics of the sample are presented, followed by the 
health outcome factors, and finally, the patient activation experienced by the sample. 
 Individual characteristics. The study sample was comprised of 64 adults who met 
inclusion criteria. The intervals of age for the study were set as follows: 40-50 years, 51-60 
years, 61-70 years, 71-80 years, and 81 or more years of age. More than one-half (n = 36, 56%) 
of the participants were between the ages of 71 and 80 years of age. Twenty-three percent of the 
sample (n = 15) reported their age between 61 and 70 years, followed by 11% (n = 7) reporting 
their age between 51 and 60 years. Nine percent (n = 6) were 81 years of age or older. The 
distribution of ages across the sample reflects the chronicity and impact of the disease on older 
adults (CDC, 2018). Though the index age for inclusion in the study was 40 years, based on the 
earliest typical onset of symptoms related to COPD, none of the patients less than 51 to 60 years 
of age approached to participate in the study did so. Almost two-thirds of the sample was women 
(n = 39, 60.9%) compared to men (n = 25, 39.1%). The sample was predominantly Caucasian (n 





or African American, one participant (2%) was American Indian/Alaskan Native, and one 
participant identified being more than one race (2%). 
 Understanding that COPD affects older adults, it was not surprising to find more than 
one-half (n = 37, 58%) of the sample indicated they were retired. Twenty-two percent (n = 14) of 
participants reported they were currently working outside of the home or were active 
homemakers (n = 4, 6%). Only nine (14%) participants indicated they were disabled or retired 
because of ill health.  
 The participants varied in their earned income levels. Fifty percent (n = 32) of the 
sample reported incomes greater than $50,000 per year, while fourteen percent (n = 9) indicted 
they preferred not to answer the question assessing income level. The majority of participants 
attended or graduated from college including: completed some college or technical school 
training (n = 26, 41%), graduated from college (n = 15, 23%), and completed postgraduate 
degree (n = 12, 19%). Only 16% (n = 10) of the sample reported the highest level of education as 
graduating from high school or completing a GED.  
 The adults living with COPD who participated in this study varied in the length of time 
since first being diagnosed with the condition. Twelve individuals (19%) reported being newly 
diagnosed in the previous three years. The majority of participants (n = 34, 53%) lived with 
COPD for the past four to ten years. Almost one-third of the sample (n = 18, 28%) reported 
being diagnosed for more than ten years.  
 Lifetime tobacco exposure is quantified by a numerical value called a pack year. One 
pack year is defined as 20 cigarettes, the quantity of a package of cigarettes, smoked everyday 
for one year (GOLD, 2018). Pack years were calculated from participant report of the total 





quantity smoked per day. Only one participant reported smoking cigars, while the rest of the 
sample reported smoking cigarettes exclusively. The calculated pack years of the sample ranged 
from 10 to 100, with the mean pack years equal to smoking an average of two packs of cigarettes 
per day for 40 years (M = 46.89, SD = 21.92).  
 Assessment of affect was included in the domain of individual characteristics, per 
Ferrans et al.’s (2005) explication of psychological factors within this domain of the model. 
Participants were asked to respond to the PANAS questions in the context of the past month to 
understand their dispositional mood traits of positive or negative affect, rather than assess them 
on a given day to obtain a situational, more temporal response. The mean positive affect sub 
score of the sample was 32 (SD = 8.86), suggesting participants had a moderate level of 
dispositional positive affect. This means that they generally had a positive outlook on life. The 
mean negative affect sub score was low at 17 (SD = 5.92), indicating participants in the sample 
generally did not have negative dispositions. This result supports the conceptual view that one 
cannot have a high positive affect and a high negative affect at the same time.  
 Finally, Body Mass Index (BMI) was calculated to assess an individual characteristic 
with strong associations to health within illness and patient activation. Body Mass Index varied 
across the sample, however the mean BMI (M = 29, SD 6.35) indicated the sample trended 
toward being overweight. Excess body weight puts additional burden on the effort and sensation 
of breathing. The highest BMI of the sample was 44, which categorized the individual as having 
Class III Obesity (very severely obese) (WHO, 2018). On the other end of the BMI spectrum, the 
lowest calculated BMI of 18 reflected an underweight participant (WHO, 2018). Significant 





uncommon for people to require assistance in maintaining weight through careful attention to 
nutrition (Celli et al., 2015). 
Table 3. Individual Characteristics of Sample  
Characteristics of the Individual n % 
Age   
51-60 7 11 
61-70 15 24 
71-80 36 56 
81 or more 6 9 
 
Gender   
Female 39 61 
Male 25 39 
 
Ethnicity   
Not Hispanic or Latino 62 97 
Unknown 2 3 
 
Race   
American Indian/Alaskan Native 1 2 
Black or African American 2 3 
White 60 94 
More than one race 1 2 
 
Marital Status   
Married 39 61 
Widowed 6 9 
Living with a significant other 3 5 
Single (never married) 2 3 
Divorced/Separated 14 22 
 
Educational Background   
Graduated high school or GED 10 16 
Some college or technical school 26 41 
Graduated college 15 23 
Postgraduate school or degree 12 19 
Not college educated§ 37 58 







Table 3. cont.   
Characteristics of the Individual n % 
Income   
Less than $10,000 3 5 
$10,000 to less than $30,000 12 19 
$30,000 to less than $50,000 8 13 
$50,000 to less than $75,000 14 22 
$75,000 to less than $100,000 9 14 
$100,000 or more 9 14 
I prefer not to answer this question 9 14 
 
Employment   
Currently working 14 22 
Retired (not because of ill health) 37 58 
Disabled and/or retired because of ill health 9 14 
Homemaker 4 6 
 
Years since diagnosis of COPD   
0-3 years 12 19 
4-10 years 34 53 
More than 10 years 18 28 
0-3 Years (Newly diagnosed)§ 12 19 
4 or more than 10 years (Older diagnosis) § 52 81 
   
 Min Max Mean SD 
PANAS: Positive Affect 14 50 32.29 8.86 
PANAS: Negative Affect□ 10 32 15.64 5.92 
Smoking: Pack Years  8 100 46.89 21.92 
Body Mass Index 18 44 28.67 6.35 
Note: N=64 
§ Denotes transformed (dichotomized) variable values 
□Base-e Log transformed Negative Affect (Min 2.3, Max 3.47, M = 2.68, SD = .34) 
 
 Environmental characteristics.  Most participants (n = 45, 70%) reported living with 
family or friends. Two-thirds of the sample were married (n = 39, 61%) or lived with a 
significant other (n = 3, 5%). Thirty percent (n = 19) of the sample reported living alone. Of 
these, twenty-one percent (n = 14) indicated they were divorced or separated, 9% (n = 6) were 





participants lived in were almost evenly split between urban and rural. Fifty-two percent (n = 33) 
of the sample indicated they lived in an urban setting of a community of more than 50,000 
people while 48% (n = 31%) of the sample reported living in a rural community of less than 
50,000 people. 
Table 4. Environmental Characteristics of Sample  
Characteristics of the Environment n % 
Living Arrangement   
     Live alone 19 30 
     Live with others 45 70 
   
Community Size 
     Rural (Community of less than 50,000 people) 31 48 
     Urban (Community of more than 50,000 people) 33 52 
   
Note: N = 64 
 Biological function. Spirometry measures are used to assess and diagnose lung function 
in COPD. The participants in this study had varying degrees of airway obstruction quantified and 
categorized by their spirometry values. The mean FEV1 of the sample was 1.26 Liters/second 
(SD = 0.59L/s) and the mean FEV1 percent predicted was 50.92 (SD = 21.54). The FEV1 percent 
predicted values indicate how the patient’s measured value (FEV1) compares to the value the 
patient should have based on their age, height, gender, and ethnicity (GOLD, 2018). These 
values are used in concert with an FEV1/FVC of less than 0.70 to classify the stage of severity of 
obstruction in COPD. Sixty-five percent of the sample had moderate (FEV1 = 50-80% predicted 
[n = 22]) to severe (FEV1 = 30-50% predicted [n = 20]) obstruction. On the opposite end of the 
distribution, 11% (n = 7) of the sample had mild (FEV1 > 80% predicted) obstruction, while 17% 





obstruction are often considered “end stage COPD” because of the dramatic limitation in airflow 
they experience (GOLD, 2018).  
Table 5. Biological Function of Sample 
Spirometry Values and Severity Staging Min Max Mean SD 
FEV1 (Liters/second) .32 2.98 1.26 .59 
FEV1 percent predicted  15 119 50.92 21.54 
     
FEV1
*  n % 
1.5 Liters or greater 22 34 
0.3 to 1.4 Liters (Low to Very low FEV1) 42 66 
 
Classification of COPD severity in patients with 
FEV1/ FVC < 0.70
** n % 
Mild (FEV1 > 80% predicted) 7 11 
Moderate (FEV1 = 50-80% predicted) 22 34 
Severe (FEV1 = 30-50% predicted) 20 31 
Very Severe (FEV1 < 30% predicted) 11 17 
   
Note: N=64 
* Categorized variable  
** Classification of COPD severity based on the GOLD (2018) Criteria 
 
 
 Symptoms. Data for this model domain were analyzed from the PFSDQ-M Dyspnea 
and Fatigue subscales. Only one participant denied experiencing dyspnea or fatigue. Participants 
reported experiencing both symptoms regularly, but most indicated relatively low symptom 
burden evidenced by the mean dyspnea (M = 23, SD = 19) and fatigue (M = 20, SD = 19) scores. 
Scores ranged from zero indicating no dyspnea or fatigue to a high of 72 (dyspnea) and 71 
(fatigue), respectively. Means, standard deviations, and ranges of each symptom were almost 
identical across the sample. High symptom burden did exist; 33% (n = 21) of the sample 






Table 6. Symptom Impact of the Sample 
PFSDQ-M Min Max Mean SD 
Dyspnea Sub score 0 72 23 19 
Fatigue Sub score 0 71 20 19 
   
Dyspnea Sub score§ n % 
Mild dyspnea§ 43 67 
Moderate to severe dyspnea§ 21 33 
   
Fatigue Sub score§ n % 
Mild fatigue§ 49 77 
Moderate to severe fatigue§ 15 23 
 
Note: N = 64 
§ Denotes transformed (dichotomized) variable values 
 
 Functional status. The responses on the PFSDQ-M Activity subscale were similar to 
those found on the Dyspnea and Fatigue subscales. Most participants (n = 48, 75%) reported a 
minor change (M = 22, SD = 21) in their functional status as compared to their pre-disease state. 
Participant total scores varied widely from 0 (No change in this activity) to 78 (Extreme change 
in this activity). Twenty-five percent of the sample (M = 22, SD = 21) experienced major 
changes in their functional status.   
Table 7. Functional Status of the Sample 
PFSDQ-M Min Max Mean SD 
Activity Sub score 0 78 22 21 
 
Activity Sub score§   n % 
Minor change in function§    48 75 
Major change in function§   16 25 
     
Note: N = 64 






 General perception of health. The global question from the Medical Outcomes Study 
SF-36 assessed general perception of health by asking, “In general, would you say your health is: 
excellent, very good, good, fair or poor?” (Ware & Sherbourne, 1992). Almost 60% of this 
sample chose Good (n = 26, 41%) or very good health (n = 12, 19%). The remaining 41% rated 
their health as fair (n = 19, 30%) or poor (n = 7, 11%). Even though most of the sample viewed 
their health positively, no participants chose “excellent” to rate their health.  
Table 8. General Perception of Health of Sample 
Single question from Medical Outcomes Study SF-36 n % 
Very Good 12 19 
Good 26 41 
Fair 19 30 
Poor 7 11 
Very Good or good§ 38 59 
Fair or poor§ 26 41 
   
Note: N = 64 
§ Denotes transformed (dichotomized) variable values 
 
 Overall quality of life.  Quality of life varied among the sample, as total scores ranged 
from 9 to 28 with higher scores indicating better quality of life. Overall, these participants 
perceived their quality of life to be moderately high as demonstrated by a mean total score of 
20.56 (SD = 4.50).  
Table 9. Overall Quality of Life of the Sample 
QLI-P Min Max Mean SD 
Overall Quality of Life 9 28 21 4.50 
     






 Patient activation. The Patient Activation Measure-13 measured the central concept of 
the study. Almost one-half of the sample was highly activated (Level 4, n = 31, 48%). Twenty-
five percent (n = 16) of the sample scored in the range of Level 3, also considered activated 
(Hibbard et al., 2004). The remaining 25% of the sample were almost evenly split between the 
lower levels of activation. Fourteen percent (n = 9) of the sample was in Level 2 activation; 
Level 1 activated participants comprised the remaining 13% of the sample (n = 8).  
Table 10. Patient Activation of the Sample 
PAM-13 Mean SD 
PAM-13: Patient Activation Score 66 16 
   
Patient Activation Levels n % 
Level 1 (PAM score ≤ 47.0) 8 13 
Level 2 (PAM score 47.1 to 55.1) 9 14 
Level 3 (PAM score 55.2 to 67.0) 16 25 
Level 4 (PAM score ≥ 67.1) 31 48 
   
Note: N = 64 
Specific Aim #2 
 The second aim of this study was to examine the unadjusted associations that patient 
characteristics and health outcome factors have with patient activation in the sample. The 
relationships between the categorical and dichotomous variables from the model and the 
outcome variable, patient activation, were explored using one-way ANOVA, while Pearson 
product-moment correlations were calculated for continuous variables and patient activation. 
Statistical significance for these tests was set at a liberal α of 0.25 to identify candidate variables 
for inclusion in the regression analysis to address Specific Aim #3. The univariate statistical 





presence, strength, and direction of relationships among the patient characteristics and health 
outcome factors with patient activation?”.  
As described previously in Chapter III, categorical candidate variables (p value of ≤ .25) 
with greater than three categories required dichotomization, based on their frequency analysis.  
These included: (a) general perception of health (good self-rated health [very good or good] and 
poor self-rated health [fair or poor]), (b) education level (college educated [completed college 
degree or postgraduate degree] and not college educated [high school/GED completion or some 
college or technical school)], and (c) time since diagnosis (newly diagnosed [0 to 3 years since 
diagnosis] and older diagnosis [4 or more years since diagnosis]). One-way ANOVAs were 
repeated and showed no change in the significance of the relationship after dichotomization of 
the variables. The final F statistics and significance are reported below. Independent variables 
with statistically significant relationships with patient activation are described in detail in Table 
11.  
Table 11. Relationships Between Independent Variables and Patient Activation Measure-13 
 
Independent Variables Univariate Analysis with Patient Activation 
Characteristics of the Individual R        ANOVA 
Age  F (3, 60) = 1.033 
Gender  F (1, 62) = 1.554† 
Race  F (3, 60) = .590 
Hispanic/Not Hispanic  F (1, 62) = .236 
Ethnicity  F (1, 62) = .236 
Marital Status  F (4, 59) = .493 
Education§  F (1, 62) = 3.312† 
Income  F (5, 58) = .756 
Employment  F (3, 60) = .708 
Body Mass Index r (62) = -.221†  
PANAS: Positive Affect r (62) = .519**  
Years since diagnosis of COPD§  F (1, 62) = 2.732† 






Table 11. cont.  
Independent Variables Univariate Analysis with Patient Activation 
Healthcare utilization    
      MD Visits§  F (2, 61) = .919 
      ED Visits§  F (2, 61) = 1.156 
 
Characteristics of the Environment R ANOVA 
Community Size  F (1, 62) = 2.95† 
Living Arrangement  F (1, 62) = .276 
 
Biological Function   
FEV1
 §  F (1, 62) = 0.86 
 
Symptoms   
PFSDQ-M: Dyspnea Sub score§  F (1, 62) = .207 
PFSDQ-M: Fatigue Sub score§  F (1, 62) = 6.614* 
   
Functional Status   
PFSDQ-M: Activity sub score§  F (1, 62) = .708 
 
General Perception of Health   
Single question from SF-36§  F (1, 62) = 4.273* 
 
Overall Quality of Life   
QLI-P r (62) = .422**  
 
Note: N = 64. Variables with relationships with patient activation with p < .25 were included in 
the Multiple Linear Regression. 
Correlation significance (2-tailed): † p < .25     * p < .05   ** p < .01 
§ Denotes transformed (dichotomized) variable values used for analysis 
 
 Characteristics of the individual. Evaluation of the variables within this domain 
revealed six to be significantly related to patient activation, which included: (a) gender, (b) level 
of education, (c) smoking pack years, (d) time since diagnosis of COPD, (e) Body Mass Index , 
and (f) positive affect. Calculation of Pearson correlation coefficients revealed patient activation 
and smoking pack years, r (62) = .319, p = .010, and positive affect, r (62) = .519, p = .001, were 





inversely related to patient activation, indicating people with lower Body Mass Index (M = 
28.67, SD = 6.35) were more activated than those with higher BMI.  
 One-way ANOVA showed significant direct relationships between patient activation 
and gender, F (1, 62) = 1.55, p = .217, level of education, F (1, 62) = 3.31, p = .074, and years 
since diagnosis of COPD, F (1, 62) = 2.73, p = .103. Women (M = 67.78, SD = 16.23) in the 
sample were more activated than men (M = 62.53, SD = 16.81). College education (M = 70.06, 
SD = 16.17) was directly related to higher activation, as was longer time since diagnosis of 
COPD (M = 67.35, SD =16.81). 
 Characteristics of the environment. One characteristic of the environment was 
significantly associated with patient activation. Community size, specifically urban communities 
greater than 50,000 people was positively, significantly (p < .05) related to patient activation, F 
(1, 62) = 2.95, p = .091. This indicated that where people with COPD reside influences their 
activation. The direction of the relationship showed that people living in urban communities (M 
= 69.11, SD = 17.30) were more activated than those living in rural communities (M = 62.13, SD 
= 15.11). 
 Symptoms. The relationship between symptom burden and patient activation was 
explored through one-way ANOVA calculations using the dichotomized dyspnea and fatigue sub 
scores from the PFSDQ-M. Only fatigue, F (1, 62) = 6.61, p = .013, was significantly related to 
patient activation. Mild fatigue (M = 68.55, SD = 16.19) was associated with greater patient 
activation among the adults in the sample than was moderate to severe fatigue (M = 56.53 SD = 
14.58) . 
 General perception of health.  Dichotomized responses to the single question from the 





were also examined for association with one-way ANOVA. A modest direct relationship 
between very good or good (M = 69.18, SD = 15.36) perceived health, F (1, 62) = 4.27, p = .043, 
and patient activation existed in the sample.  
 Overall quality of life. The total score of the QLI-P reflected participants’ perception 
of their overall quality of life. Pearson correlation coefficient revealed patient activation and 
overall quality of life were strongly correlated, r (62) = .422, p < .001 within the sample.  
Specific Aim #3  
 The final aim of the study was to identify the independent predictors of patient 
activation in the sample. Stepwise linear regression was calculated to predict the percentage of 
variance that the candidate patient characteristics and health outcomes explained in patient 
activation among the sample of adults living with COPD. Independent variables whose 
univariate test had a significant association with patient activation at a liberal alpha of 0.25 were 
included in the multivariate regression analysis. These variables are referred to as candidate 
variables from this point forward. Ten candidate variables entered the stepwise linear regression 
with patient activation. These included gender, Body Mass Index, education level, smoking pack 
years, years since diagnosis of COPD, positive affect sub score, community size, fatigue sub 
score, general perception of health, and overall quality of life. 
 Together, a statistically significant model containing four independent predictors 
accounted for 45.4% of the variance in patient activation among adults with COPD.  See Table. 
12. Positive affect, β = .457, t (4.60) p = .001 contributed most to the explanation of variance in 
patient activation, followed by smoking pack years, β = .345, t (3.693), p = .001 and overall 





was gender. Female gender was significantly correlated with patient activation, β = -.192, t (-
2.053), p = .044.   
Table 12. Multiple Linear Regression with Predictor Variables 
Independent 
Variables 
B SE β t p 
      
Positive affect  .852 .185 .457 4.600 .001 
Pack years .260 .070 .345 3.693 .001 
Quality of life .972 .364 .264 2.670 .010 
Gender -6.443 3.138 -.192 -2.053 .044 
      
Note: N = 64 
Constant = 0, p = .123 
R2 = .488, Adjusted R2 = .454, F (4, 59) = 14.079, p < .001  
 
  Multivariate assumptions. No multicollinearity was identified among the predictors 
and patient activation based on the tolerance values [.88 - 1.00] and variable inflation factors 
[1.00 – 1.13]. The highest reported correlation index was 15.80, associated with gender entering 
the model. This finding suggests that some collinearity may exist between gender and at least 
one other predictor variable. Based on consideration of all three factors, it was determined that 
multicollinearity was not a concern in the analysis. 
 Assumptions of normality in the regression were evidenced by a normally distributed 
histogram of the regression standardized residuals and linear relationship between the observed 
and expected probabilities of the residuals. Viewing the standardized residuals and predicted 
values on a scatterplot assessed Homoscedasticity. The plotted residuals did not completely 
mirror each other above and below the line, but were equally distributed above and below the 
line. While the scatterplot did not indicate that the assumption of homoscedasticity was 
completely violated, the appearance suggested that the variance noted in patient activation may 





interaction variable was created and the stepwise linear regression was calculated again. No 
visual difference in the scatterplot was noted when including the interaction variable in the 
analysis. It was concluded that normal distribution and linear relationship of the residuals 
satisfactorily affirm the assumption of normality was met for the analysis. 
 Calculating Mahalanobis distance and Cook’s distance during the regression assessed 
multivariate outliers. The highest Mahalanobis distance of 8.6916 was significantly less than the 
χ2 critical value of 18.467. Cook’s distance values were all less than one, confirming the absence 
of multivariate outliers impacting the regression. 
 Post hoc power analysis. Initial power analysis using G*Power 3 software (Faul et al., 
2009) for multiple linear regression indicated that 98 participants would be needed, assuming an 
anticipated conservative medium effect size of f2 = 0.15, based on the work of Korpershoek et al. 
(2016). A post hoc power analysis was conducted after the regression analysis. The actual 
sample size of 64 participants, four independent predictor variables, alpha of p < .05, and 
calculated effect size of f2 = .95 (based on R2 of .488) were entered into the statistical power 
analysis. The post hoc analysis revealed the statistical power for the study was .99 for the overall 
regression in prediction of patient activation in the sample. Substantial power and the large effect 
size to detect the strength of the relationship between the predictor variables and patient 
activation affirm the validity of the regression results despite the small sample size analyzed.  
Summary 
 This dissertation study proposed to describe and examine the relationships among 
patient characteristics and health outcome factors, as conceptualized in the Revised Wilson 
Cleary Model (Ferrans et al., 2005), as determinants of patient activation in adults with COPD. 





influenced among adults experiencing the complex, multidimensional health affects of COPD. 
The results of this dissertation study indicate that several patient characteristics (gender, level of 
education, time since COPD diagnosis, smoking pack years, Body Mass Index, positive affect, 
community size) and health outcomes (low fatigue, general perception of health, quality of life) 
were significantly associated with patient activation. In multivariate analysis, positive affect, 
smoking pack years, overall quality of life, and female gender independently predicted 45% of 







 This chapter presents a summary of the study and important conclusions drawn from the 
data analyses presented in Chapter IV. The results are organized by each specific aim and related 
to the current body of research literature. In addition, this chapter provides a discussion of the 
implications for nursing clinical practice, theory development, and recommendations for future 
research.  
Study Overview  
 Skills, confidence, and knowledge underpin the capacity of individuals with chronic 
disease to self-manage (Hibbard et al., 2015). These characteristics and a sense of responsibility 
for one’s own health comprise the concept of patient activation (Hibbard et al., 2004). Patient 
activation has been shown to be a precursor to successful self-management and predictor of 
health outcomes in chronic disease (Green et al., 2015). The concept of patient activation has 
relevance in the treatment of COPD, a progressive incurable lung disease, where the onus of 
treatment success lies in the capacity of the patient to engage in self-management intensive 
treatment plans.  
Problem and Purpose 
 There are two key problems noted in the COPD and patient activation research 
literature. First, the COPD research community has called for further inquiry to identify and 





 characteristics may hold the key to understanding why less than one-half of all people with 
COPD engage in recommended self-management. The current evidence is not only insufficient; 
it is clouded by conflicting results of self-management intervention studies of the past decade. 
Second, despite the emerging body of evidence suggesting patient activation is a critical 
construct in chronic disease care (Coventry et al., 2014; Green, et al., 2015), determinants and 
mediators of the concept are still relatively unknown (Hibbard, et al., 2015). Additionally, little 
is known about how the complex, systemic nature of COPD affects patient activation 
development (Evans & Morgan, 2014; Korpershoek, et al., 2016).   
 The purpose of this study was to describe and examine the relationships among patient 
characteristics and health outcome factors as determinants of patient activation level in adults 
with COPD.  To guide this cross-sectional, descriptive correlational study, the Revised Wilson 
Cleary Model (Ferrans et al., 2005) was adapted by adding the concept of patient activation to 
the model. Patient activation was integrated as an additional outcome concept with overall 
quality of life as they share similar integrated biopsychosocial complexity (Hibbard & Mahoney, 
2010). The model organized a continuum of complex and integrated health outcomes and patient 
characteristics integral to the experience of COPD for study (Guyatt, et al., 2007). The specific 
aims to be addressed by the study were to: (a) describe the patient characteristics (individual and 
environmental), health outcome factors (biological function, symptoms, functional status, 
general perception of health, and overall quality of life), and patient activation experienced by a 
cross-sectional sample of adults in the United States with COPD; (b) examine the unadjusted 
associations that patient characteristics and health outcome factors have with patient activation in 





 A random sample of adults who received care for COPD at the study site were invited 
to participate in a postal survey study. Data were collected from 64 participants through 
completion of a questionnaire comprised of validated tools aligned with each of the domains of 
the conceptual framework guiding the study. In addition, spirometry data were abstracted from 
participants’ medical records. The presence, strength, and directionality of relationships between 
the patient characteristics, health outcomes and patient activation were examined through 
univariate correlation analyses. The patient characteristics and health outcomes significantly 
associated with patient activation were then entered into stepwise linear regression models to 
identify the variables that explained the greatest variance in patient activation.  
Major Findings 
Participants in this study were mostly older men and women in their 70s. Few 
respondents lived alone as most were married or living with a significant other. The majority had 
been diagnosed with COPD for several years; their most recent spirometry revealed moderate to 
severe airway obstruction. They had significant smoking pack years and were overweight. 
Socioeconomically, the sample was educated, living in urban communities, and had incomes 
greater than $50,000 per year. The sample’s demographics were consistent with the known 
demographics of the COPD population in the United States (CDC, 2017; Croft et al., 2018). 
Despite having significant obstructive lung disease, the participants had few physician visits and 
emergency room visits in the past year. Except for one person, all participants experienced 
symptoms of fatigue and dyspnea, and noted a change in their current functional status as 
compared to before being diagnosed with COPD. The degree of impact of the symptoms and 
change in function was mild for most of the sample. Notably, the degree of positive affect, or an 





 This study found statistically significant associations between individual and 
environmental characteristics, specifically gender, Body Mass Index, educational level, smoking 
pack years, time since COPD diagnosis, community size, and patient activation. Additionally, 
the health outcomes of fatigue, general perception of health, and overall quality of life were 
positively related to patient activation in the sample. Multivariate regression analysis revealed 
four determinants, positive affect, smoking pack years, overall quality of life, and gender, which 
together explained 45.4% of the variance in patient activation. The next section will discuss the 
major findings related to patient activation and the new knowledge emerging from this study. 
Major Findings Related to Patient Activation  
 Patient activation is an important factor when planning care with patients diagnosed 
with COPD. The goals of COPD treatment plans are to limit physical and lung functional decline 
and maintain quality of life (Qaseem et al., 2011). Diligent self-management by patients is 
required to achieve these goals. People with higher patient activation are more likely to 
participate in recommended activities associated with collaborative self-management treatment 
plans for COPD (Dixon, Hibbard & Tusler, 2009). 
The mean Patient Activation Measure-13 (PAM) score of the sample was 66 (SD = 16) 
(maximum score 100), which lies near the cut-off point between PAM Level 3 and 4. According 
to Hibbard et al., (2005), this score indicates that the majority of participants in the sample were 
activated and would be able to begin taking action toward self-management by initiating new 
health behaviors. Forty-eight percent of the sample participants (n = 31) were highly activated at 
PAM Level 4. At this level, it would be expected that these individuals were engaged in their 
self-management and with their providers. In times of stress (e.g., COPD exacerbation) they may 





management routines (Hibbard et al., 2005). Fourteen percent of the sample were in Level 2 
activation, associated with early awareness of the need to do more for their health, yet having 
little knowledge and sense of efficacy to make any changes on their own (Hibbard et al., 2004). 
The remainder of the sample was in the lowest level of activation, Level 1. This group would 
have a passive perspective toward taking responsibility to manage their health because of limited 
knowledge about their condition and believing their doctor should be in charge of their health 
(Hibbard et al., 2004). 
 The patient activation scores found in this study sample were higher than those reported 
by Halding and Grov (2017) and Korpershoek et al. (2016) in their examinations of Dutch adults 
with COPD. While Halding and Grov examined community dwelling adults’ activation levels, 
Korpershoek et al. (2016) included patients living in skilled nursing facilities and community-
dwelling adults with COPD in their examination patient activation determinants. Korpershoek et 
al. (2016) did not report if there were differences in PAM scores between the community-
dwelling participants and those in skilled care settings. Clinically, there should be a distinction in 
patient activation scores among people who live in skilled care facilities and are not autonomous 
in managing their health. As evidenced by the high capacity to self-manage (PAM Levels 3 and 
4) and health outcomes reported, the findings suggest that most of the sample were self-
managing their COPD.  
Significant Relationships Among Variables and Patient Activation 
 Univariate statistical analyses were conducted to explore the presence, strength, and 
direction of relationships between the variables described in each of the domains of the Revised 





living with COPD significantly associated with their patient activation level provide a picture of 
activation in this population that are not yet described in the literature.  
 Consistent with other studies of determinants of patient activation, this study found 
lower BMI was associated with higher patient activation (Korpershoek et al., 2016; Liu et al., 
2014). The majority of the participants in this sample were overweight or obese (M =28.67, SD = 
6.35), (WHO, 2018). Ding et al., 2017 noted that being overweight with COPD is prevalent in 
the world. They found that 74% of the people with COPD in U.S. studied were overweight or 
obese, compared to 60% in the European countries studied. Their study corroborates the subtle 
differences noted in overweight BMI of this U.S. sample and that of Korpershoek et al., (2016) 
in the Netherlands. How BMI influences activation levels has not been discussed in the literature 
and warrants further study. 
 Lower symptom burden, specifically fatigue, was related to activation in the sample. 
The fact that fatigue, not dyspnea, was associated with patient activation was an interesting 
finding. Though fatigue is known to be prevalent in COPD, dyspnea is the predominant symptom 
assessed clinical research. Controlling fatigue and dyspnea are self-management behaviors 
considered most worthwhile by those with COPD (Chen et al., 2008) and together significantly 
contribute to decreased quality of life (Guyatt et al., 2007). The processes by which fatigue and 
activation were associated in this sample deserve further investigation. 
 Sociodemographic factors, higher levels of formal education and larger community 
sizes were strongly associated with higher patient activation scores in analysis. These findings 
were consistent with the Dutch sample of people living with COPD examined by Korpershoek, 
et al., (2016). Acquiring and applying the necessary skills, knowledge, and confidence to self-





others have posited that a higher level of formal education improves health literacy, positively 
impacting patient activation levels over time (Green et al., 2015; Hibbard et al., 2007, 2015; 
Marshall et al., 2013). Formal education develops problem solving ability and cognitive skills to 
distill and apply knowledge (Heide et al., 2013). Further, education develops “soft skills” of 
control, autonomy, and personal efficacy (Zimmerman et al., 2013). These skills underpin the 
construct of patient activation. (Hibbard et al, 2004; Hibbard & Mahoney, 2010). In addition, 
living in an urban community has been proposed to support higher activation of people with 
chronic disease by having greater access to health care and less social isolation (Chen et al., 
2014). Similarly, other authors have posited limited health care resources and isolation in rural 
communities as contributing to lower patient activation among older adults with COPD living 
there (Croft et al., 2018).  
 People who had lived with the disease longer (four or more years) were more activated 
in the sample of this study. There was a moderately significant association between the years 
since diagnosis with COPD and patient activation. This finding is supported by Hibbard and 
Mahoney’s (2010) assertion that the length of time people live with a chronic condition is 
positively related to their activation. The authors rationalized that the more experience people 
have managing the good and bad days common in chronic disease, the greater they develop 
efficacy and knowledge, which fosters activation for self-management. This result is contrary to 
the findings of Korpershoek et al., (2016) which showed lower patient activation was associated 
with greater number of years living with the diagnosis of COPD. The results of this analysis 
warrant further study to better understand the high levels of activation in later years of COPD.  
 Congruent with the conceptual model used in this study, integrated physiological and 





(Bentsen et al., 2008). Among the sample, a significant relationship favoring very good or good 
(M = 69.18, SD = 15.36) perceived health and patient activation was found. This is corollary to 
findings in other chronic disease studies of poor perception of health positively associated with 
lower patient activation scores (Chubak et al., 2010; Hibbard et al., 2015). Self-rated health has 
been found to independently predict COPD-related mortality across diverse epidemiological 
samples (Benzo et al., 2010; Nguyen et al., 2008; Park and Larson, 2016; Wagner & Short, 
2014), thus it has become an integral factor in patient assessment.  
Determinants 
 Among the people in the sample, their high positive affect and perception of overall 
quality of life, combined with the life experiences of gender and smoking, explained almost 45% 
of the variance in their patient activation. How each of the independent predictors contributed to 
the model provides further insight to the unique impact of COPD on activation. Positive affect 
and perception of quality of life were strongly correlated with patient activation and contributed 
to the regression model. The mechanisms of smoking pack years and gender on the development 
of patient activation are less clear. Each of the determinants and their relationship with patient 
activation in the context of the COPD population are discussed below. 
 Positive affect. “Emotions are key underpinnings of activation” (Hibbard & Mahoney, 
2010, p. 378). In development of the Patient Activation Measure, Hibbard et al. (2004) asserted 
that positive affect contributed significantly to developing an individual’s self concept as a self-
manager, the outward expression of their activation level. Positive affect was strongly positively 
correlated with patient activation in the sample. This is the first time positive affect has been 
identified as a predictor of activation level in the literature. The mean positive affect sub score of 





moderate level of dispositional positive affect. This means that they generally had a positive 
outlook on life and feelings of optimism (Watson et al., 1988). The mean negative affect sub 
score was low at 16 (SD = 5.9), indicating participants in the sample generally did not have 
negative dispositions and pessimistic views on life. Considering most of the sample had lived 
with COPD for many years, well-established positive emotions and an optimistic outlook on life 
may have contributed to their activation development.  
 The role of positive emotions is relevant to the trajectory of COPD where in progression 
of symptoms, debility, and acute exacerbations require emotional resources to adapt and problem 
solve (Bentsen et al., 2008). In the context of collaborative self-management of COPD, positive 
affect has been associated with better health management and engagement with the healthcare 
team (Benzo et al., 2016). Further, the ratio of positive to negative affect, or positivity ratio, of 
people living with COPD has been shown to mediate the relationship between patient’s 
investment in self-management behavior and better overall quality of life (Benzo et al., 2016). 
Identifying positive affect as a strong predictor of self-management capacity in COPD provides a 
target for nursing interventions to improve self-management and activation levels of patients 
with COPD. 
 Overall quality of life. In this study, univariate analysis revealed patient activation and 
overall quality of life were strongly correlated. Therefore, adults in the sample who perceived 
their quality of life as better were more activated. This finding is congruent with studies of other 
chronic disease populations (Dixon et al., 2009; Goodworth et al., 2016; Hibbard et al., 2007, 
2015; Mosen et al., 2007). More importantly, this study found a predictive relationship between 
quality of life and patient activation, β = .264, t (2.670), p = .010, which for the first time 





management capacity of people living with COPD. Examination of any measure of quality of life 
was notably absent in Korpershoek et al.’s (2016) study of determinants of patient activation in 
COPD. This is an important finding linking the COPD and patient activation literature related to 
self-management and subsequent health outcomes. The perception of one’s quality of life is a 
powerful predictor of COPD-related health behaviors, co-morbidity, mortality, and health care 
utilization (Case et al., 2017; Guyatt et al., 2007). Patient activation also predicts, mediates, and 
directly influences self-management engagement and health outcomes in chronic disease (Green 
et al., 2015; Hibbard et al., 2015). 
Improving quality of life through collaborative self-management and medical 
intervention is a priority in COPD care (Qaseem et al., 2011). Though the literature has 
suggested activation level and quality of life may be related through the process of self-
management in chronic disease (Dixon et al., 2009), the relationship between quality of life and 
patient activation has not been previously studied with sufficient rigor in the COPD population. 
It is unclear if better perceived quality of life supports or maintains patient activation, or if higher 
activation and subsequent health outcomes lead to improved quality of life (Goodworth et al., 
2016). This important link between quality of life and patient activation must be investigated 
further to understand how the relationship can be translated practically to the care of patients 
with COPD.  
 Smoking pack years. More than 75% of all COPD diagnoses are attributed to smoking 
(CDC, 2017). When diagnosed with COPD, many people express guilt that their conscious use 
of cigarettes led to their diseases. The quantity of cigarettes or cigars smoked over time by 
(participants in this study averaged 47 pack years. This would suggest that most participants 





the sample are indicative of the national norm of a pack-to-two-pack per day smoker of the late 
1950s and 1960s (Gardner, 2011), when most of the samples were likely introduced to smoking. 
 The direct, predictive relationship found between smoking pack years, β = .345, t 
(3.693), p = .001, and patient activation is an interesting finding. First, the correlation between 
the two variables indicates that people in the sample who were heavier smokers, as quantified by 
their pack years, were more activated than people who smoked less. Second, higher pack years 
strongly contributed to the model explaining the variance in patient activation among the sample. 
No other studies identified through literature review examined the association between smoking 
pack years and patient activation. Other studies of patient activation determinants examined 
smoking habits (active or former) but not quantity of tobacco smoked. Korpershoek et al. (2016) 
found smoking habits were associated with patient activation level in people with COPD. 
However, the variable did not explain variance in patient activation in their regression analysis. 
Studies of patient activation determinants in other chronic disease populations did not find any 
relationship between smoking habits with patient activation (Dunlay et al., 2017; Schmaderer et 
al., 2016).  
 While the mechanisms are unclear why smoking pack years contributed significantly to 
the model, the result cannot be ignored. To explore reasons for this result, consideration of the 
theoretical underpinnings of patient activation and nature of cigarette smoking must be 
considered. It can be posited that a unique sense of personal responsibility exists among people 
with COPD. Many people express significant guilt regarding their smoking habits when 
diagnosed with COPD (Celli et al., 2015). As most COPD is attributed directly to cigarette 
smoking, patients who are current or former smokers seem to accept a degree of responsibility 





smoked is influenced by social norms, finances, and perceived effect from smoking (Benowitz, 
2010). These factors contribute to many with COPD having high smoking pack years. To smoke 
tobacco in an environment of social pressures and strong recommendations from healthcare 
providers requires people to make conscious decisions and problem solve to maintain this 
behavior, even if it is a risk to their health and socially undesirable. Responsibility and 
confidence in making decisions about one’s health underpin activation (Hibbard et al., 2004). 
 Capability and confidence also underpin activation (Hibbard et al., 2004). The addictive 
properties of nicotine in tobacco promote the long-term habituation to cigarette smoking 
(Benowitz, 2010). Quitting smoking is a significant self-management success, one that builds 
efficacy and can be leveraged toward other self-management behaviors in the setting of COPD. 
Efficacy is central to capability and confidence to make behavioral changes to support self-
management (Hibbard & Mahoney, 2010). Participants with greater pack years who had 
successfully quit smoking may see achieving this goal as a pivotal success in their health. 
Clearly, the role of smoking within this sample of adults with COPD who were highly activated 
warrants further study to explicate and understand these factors.  
 Gender.  Gender has had inconsistent associations with patient activation and several 
elements of care in COPD in the literature. In this study, even though gender was only modestly 
associated with patient activation in univariate analysis, it did contribute to the overall regression 
model explaining variance in patient activation score. Specifically, males were less activated 
than females in all analyses. Other researchers have warned that associations between gender and 
patient activation should be considered cautiously in samples with unequal gender distribution 
(Green et al., 2015; Hibbard et al., 2015). Women outnumbered men by 20% in this sample. 





activation have also had disproportionately large numbers of women in the samples (Fowles et 
al., 2009; Goodworth et al., 2016; Hibbard et al., 2005, 2015, 2016). However, none of the 
studies published to date have identified gender as an independent predictor of patient activation. 
This is a unique finding of this study.  
 The process underlying greater activation among women in the sample is not entirely 
clear. How women’s experiences in chronic disease, as opposed to men’s, impact activation has 
not been explored in the literature. Similarly, the differences between men and women in terms 
of their experiences with COPD have only recently begun to be examined and reported in the 
literature. Awareness of the differences between women and men in relation to COPD only 
emerged when the numbers of newly diagnosed and mortality rates began to favor women in the 
early 2000s (ALA, 2017; Celli et al., 2015; Pruitt, 2014). Evidence has shown that smoking 
habits, environmental exposures, genetic predisposition, symptoms and even response to 
treatments vary between the sexes (Jenkins et al., 2017). Women are more likely to be diagnosed 
later in the disease trajectory when symptoms and obstruction are greater (Jenkins et al., 2017). 
However, once diagnosed women have more healthcare encounters and interactions with 
providers than men (Jenkins et al., 2017). The timing of diagnosis, life experiences, and exposure 
to providers may contribute to the skills and knowledge that predicate activation (Hibbard et al., 
2007). The relationship between gender, patient activation level, and self-management requires 
further study to understand how these factors may influence outcomes for women with COPD. 
Summary and Implications 
 This descriptive correlational study expands the limited scientific knowledge of 
determinants of patient activation of adults living with COPD in the United States. Cognitive-





(Kaptein et al., 2014; Korpershoek et al., 2016). The results provide: (a) insight to the 
characteristics and health outcomes experienced by a sample of people living with COPD in this 
country, (b) knowledge of significant relationships and determinants among these factors and 
patient activation, and (c) objective targets for future COPD self-management research. Further, 
the results from this study address a gap in in the evidence base related to the patient factors 
necessary to engage in self-management of COPD. Based on the findings, implications for 
nursing clinical practice, theory advancement, and future research are presented.  
The multidimensional Revised Wilson Cleary Model of Health-related Quality of Life 
(Ferrans et al., 2005) was used to organize and examine phenomena unique to people living with 
COPD as they related to patient activation. The model builds from the singular, objective 
biological factors to the highly integrated, complex overall quality of life (Wilson & Cleary, 
1995). Patient activation was integrated as an end-point in the model as it shares similar 
biopsychosocial complexity with overall quality of life (Hibbard & Mahoney, 2010). 
Unidirectional relationships between variables in each model domain, except biological function 
and functional status, were revealed across the continuum of increasing complexity with patient 
activation. Though the model was not tested for fit and reciprocal relationships among the 
domains were not explored in this study, the domains and proposed relationships among them 
contributed to the results of this study. The characteristics of the individual, explicated by 
Ferrans et al. in 2005, provided most of the variables significantly associated with activation 
level of people living with COPD. Adaptation to include patient activation as an end-point in the 
model was supported by the strong correlation found between overall quality of life and patient 
activation in the sample. Guyatt, Ferrans, and colleagues (2005) suggested that in the setting of 





influence the individual’s perception of overall quality of life. Further study of the relationships 
between and among the domains of the model may reveal integration of the domains and patient 
activation not identified in this study.  
Implications for Nursing Clinical Practice 
 Findings from this study will inform nurses who care for patients with COPD what 
patient activation is, how it is related to self-management outcomes, and what patient 
characteristics influence it. The independent predictors of patient activation provide new targets 
for self-management interventions to improve engagement and support activation development 
in people with COPD. In addition, this study identified several characteristics and health 
outcomes of people living with this condition significantly associated with their patient 
activation level. Nurses are in a pivotal position to apply knowledge of activation predictors 
toward identification of self-management capacity of patients and engage them in appropriate 
behavioral interventions and care coordination services (Hibbard & Greene, 2013; Naylor et al., 
2013).  
• Patent activation is an important characteristic to assess and explore with patients as to its 
potential to be modified and contribute to self-management engagement and health 
outcomes. Use of the Patient Activation Measure (Hibbard et al., 2005) in the clinical 
setting could contribute to improved care in this population.  
• Using the PAM to assess and evaluate patients participating in self-management, care 
coordination, and pulmonary rehabilitation programs would provide objective measure of 
self-management capacity to tailor the care plan and meaningfully evaluate outcomes. 
Further, PAM scores can indicate how intensely to follow high-risk patients in care 





• Measurement of the patient activation score can augment clinical risk prediction for 
emergency department visits and hospitalization rates, directly associated with all-cause 
mortality in the COPD population (Dhamane et al., 2015; Hibbard et al., 2016). Patients 
with PAM Level 3 and 4 are significantly less likely to have a costly emergency room 
visit and subsequent hospitalization as compared to those at Level 1 (Hibbard et al., 
2016). 
• The importance of thorough psychosocial assessment of people with COPD prior to 
planning interventions and supportive care for self-management cannot be understated. 
Mood, affect, self-rated health, and perception of quality of lives are strongly associated 
with activation level and self-management capacity of patients.  
• Positive affect and overall quality of life present modifiable targets for strengths-based 
nursing interventions to improve self-management engagement and health outcomes 
among people living with COPD (Gottlieb and Gottlieb, 2017).  
• Quantification of pack years should be included in assessment of smoking status of 
people with COPD. Smoking history may reflect a hidden strength among people with 
COPD that contributes to their activation level, and thus, capacity to self-manage. 
Implications for Nursing Theory Advancement 
 The Revised Wilson Cleary Model of Health-related Quality of Life (Ferrans et al., 
2005) provided an adaptable, comprehensive frame to examine the unique patient characteristics 
and health outcomes of people living with COPD and their relationships with patient activation. 
It is recommended that the associations between and among the domains of the model and 
patient activation are examined with larger sample sizes to fully explicate the relationships found 





modeling is recommended to test the fit of the model for future exploration of causal 
relationships and prediction of patient activation precursors. Advancement of this theory could 
potentially identify mechanisms of patient activation development that underlie self-management 
efficacy across chronic disease states. Use of the model to organize and describe the findings of 
this study demonstrated the utility of the model to advance the understanding of patient 
activation in COPD, filling a gap in the literature.  
Recommendations for Future Research 
 This was the first study of its kind to describe patient characteristics and health 
outcomes associated with patient activation in people living with COPD in the U.S. In addition, 
this study contributed four unique determinants of patient activation, expanding knowledge of 
this concept within the minimally studied COPD population. However, this study does not exist 
in isolation. Further study is needed with more diverse samples to fully explicate the significant 
associations, predictors, and relationships among them and patient activation. Mixed-methods 
approaches are needed to explore the lived experience of adults with COPD at various levels of 
patient activation. This would provide rich knowledge missing from the current literature, and 
perhaps reveal other factors relevant to lend additional support for the predictors explicated in 
this study.  
 Adoption of the Patient Activation Measure (Hibbard et al., 2004) as a core outcome 
measure in COPD self-management studies is needed. Not only can the PAM provide a sensitive 
evaluation measure of intervention efficacy, it can be used to tailor self-management 
interventions to move patients developmentally to their optimal level of activation. Use of the 
PAM would address the heterogeneity prevalent in COPD self-management outcomes and 





recommendations of the National Institute of Nursing Research (Grady & Daley, 2014; Moore et 
al., 2016). 
 Recruitment of patients in exploratory and behavioral COPD research is challenging 
(Benzo et al., 2017). Though response rate was low for this survey, it was encouraging to see so 
many people with severe and very severe (end stage) COPD agree to participate. Few young and 
less affected (mild COPD) people identified participated, consistent with other COPD studies 
that identified those less affected did not believe they were sick enough or were not sure they 
“had COPD” (Benzo et al., 2015). To capture the entire range of COPD severity and experiences 
in this population, strategies to optimize survey design and return rate for optimal sample size 
and diversity must be explored. 
 Additional questions should be asked of participants to gain deeper understanding of the 
results of this study. First, questions to assess the relationship between current and former 
smoking practices in the context of pack years are needed to explain the strong association 
between smoking pack years and patient activation. Second, as patient activation is modifiable 
and developmental, asking participants about prior pulmonary rehabilitation or participation in 
collaborative self-management programs (i.e., nurse-led educational programming in 
comprehensive pulmonary care center) is recommended. This information would shed light on 
exposure to behavioral interventions that may have increased the patient activation level of the 
sample.  
Conclusion 
 Patient activation is an important construct that can contribute to the advancement of 
COPD self-management science and nursing care. COPD multidimensionality affects the 





management engagement and positive health outcomes associated with greater activation are 
important in the setting of COPD. This study revealed several mechanisms of complex health 
behaviors that underlie self-management capacity in COPD. Thorough nursing assessment of 
patient characteristics, including outlook on life, social history (smoking), gender, and 
satisfaction with their quality of their life will provide meaningful insight to the capacity of an 
individual with COPD to self-manage their disease. Use of the Patient Activation Measure 
(Hibbard et al., 2004, 2005) in clinical settings and self-management research would positively 
contribute to the care of this vulnerable population. Further research is needed to explicate the 



















Positive and Negative Affect Scale (PANAS) 
 
This scale consists of several words that describe different feelings and emotions. Read each 
word and then circle the choice that best describes to what extent you are feeling this way in the 





not at all 





1. Interested……...... 1 2 3 4 5 
2. Distressed………. 1 2 3 4 5 
3. Excited…………. 1 2 3 4 5 
4. Upset…………… 1 2 3 4 5 
5. Strong…………... 1 2 3 4 5 
6. Guilty…………... 1 2 3 4 5 
7. Scared………….. 1 2 3 4 5 
8. Hostile………….. 1 2 3 4 5 
9. Enthusiastic…….. 1 2 3 4 5 
10. Proud…………… 1 2 3 4 5 
11. Irritable………… 1 2 3 4 5 
12. Alert……………. 1 2 3 4 5 
13. Ashamed……….. 1 2 3 4 5 
14. Inspired………… 1 2 3 4 5 
15. Nervous………... 1 2 3 4 5 
16. Determined…….. 1 2 3 4 5 
17. Attentive……….. 1 2 3 4 5 
18. Jittery…………... 1 2 3 4 5 
19. Active………….. 1 2 3 4 5 
20. Afraid………….. 1 2 3 4 5 
 
Watson, D., Clark, L. & Tellegen, A. (1988). Development and validation of brief measures of positive and negative 









Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQ-M) 
 
DEGREE OF SHORTNESS OF BREATH ASSESSMENT 
 
INSTRUCTIONS: The following questions relate to your discomfort in breathing.  Please 
check the most accurate answer. 
 
1. Do you ever experience shortness of breath? Yes_____ No_____ 
 
2. How many times a month do you experience severe to very severe shortness of breath? 
__________ 
 
Using the following scale, place a mark on the line between 0 (no shortness of breath) to 10 
(very severe shortness of breath) in response to the following questions. 
3. Indicate how you've felt on most days during the past year. 
   M i l d  M o d e r a t e S e v e r e     Very severe 
No shortness      
    shortness 
   of breath     0     1  2  3     4     5    6     7      8      9     10   of breath 
4. Indicate how you feel today. 
   M i l d  M o d e r a t e S e v e r e     Very severe 
No shortness      
    shortness 
   of breath     0     1  2  3     4     5    6     7      8      9     10    of breath 
5. Indicate how you feel with most day-to-day activities. 
   M i l d  M o d e r a t e S e v e r e     Very severe 
No shortness      
    shortness 
   of breath     0     1  2  3     4     5    6     7      8      9     10    of breath  
DEGREE OF SHORTNESS OF BREATH ASSESSMENT 
 
 
Lareau, S. C., Breslin, E. H., & Meek, P. M. (1996). Functional status instruments: outcome measure in the 
evaluation of patients with chronic obstructive pulmonary disease. Heart & Lung: The Journal of Acute and Critical 







INSTRUCTIONS:  Rate the following activities on a scale of 0 to 10 according to the 
degree of shortness of breath each activity generally causes you. 
 
Complete the form as follows:  Place an “X” in the column under “0” if the activity 
generally causes you no shortness of breath.  Leave blank those activities you do not 




None          Mild       Moderate       Severe 
Very 
Severe 
    0    1    2    3   4    5   6   7    8    9   10 
1. Brushing/combing hair 
           
2. Putting on shirt            
3. Washing hair 
           
4. Showering 
           
5. Raising arms overhead            
6. Preparing a snack 
           
7. Walking ten feet (3½ 
meters) 
           
8. Walking on inclines 
           
9. Walking on bumpy 
terrain 
           
10. Climbing 3 stairs            
 
DEGREE OF TIREDNESS ASSESSMENT 
INSTRUCTIONS:  The following questions relate to how tired or worn out you feel.  Please 
check the most accurate answer. 
 
1. Do you ever experience tiredness/feeling worn out?      Yes__  No_____ 
 
2. How many times a month do you experience severe to very severe tiredness? ________ 
 
Using the following scale, place a mark on the line between 0 (no tiredness) to 10 (very 





3. Indicate how you've felt on most days during the past year. 
    M i l d   M o d e r a t e S e v e r e 
No Tiredness 
 Very Severe 
 0     1  2  3    4    5    6     7     8      9     10          Tiredness 
4. Indicate how you feel today. 
   M i l d   M o d e r a t e S e v e r e 
No Tiredness 
 Very Severe 
 0     1  2  3    4    5    6     7     8      9     10          Tiredness 
5.  Indicate how you feel with most day-to-day activities. 
    M i l d   M o d e r a t e S e v e r e 
No Tiredness 
 Very Severe 




None          Mild       Moderate       Severe 
Very 
Severe 
    0    1    2    3   4    5   6   7    8    9   10 
1. Brushing/combing 
hair            
2. Putting on shirt            
3. Washing hair 
           
4. Showering 
           
5. Raising arms 
overhead 
           
6. Preparing a snack 
           
7. Walking ten feet 
(3½ meters) 
           
8. Walking on inclines 
           
9. Walking on bumpy 
terrain 
           







INSTRUCTIONS:  The following is a list of activities commonly performed by adults.  For 
each activity listed, please place an X in the appropriate box, indicating your involvement with 
the activity now as compared to before you developed breathing problems.  Please respond to 
every activity listed. 
Complete the form as follows: 
1."Has never been an Activity":  Check this box near each activity in which you have never 
participated. 
2. Columns numbered 0 through 10 represent a range of activities from "As Active As I've Ever 
Been" to "Have Omitted Entirely".  Indicate by placing an X in the area which best reflects 
























































































1. Brushing/ combing hair 
 0 1 2 3 4 5 6 7 8 9 10 
2. Putting on a shirt  
           
3. Washing hair 
            
4. Showering 
 
           
5. Raising arms overhead 
 
           
6. Preparing a snack 
            
7. Walking 10 feet (3.5 meters) 
 
           
8. Walking on inclines 
 
           
9. Walking on bumpy terrain  
           
10. Climbing 3 stairs  







Appendix C  
Quality of Life Index Pulmonary Version-III 
 
Part 1. For each of the following, please choose the answer that best describes how satisfied you 
are with that area of your life. Please mark your answer by circling the number. There are no 
right or wrong answers. 
 











































































1. Your health? 1 2 3 4 5 6 
2. Your health care? 1 2 3 4 5 6 
3. The amount of pain you have? 1 2 3 4 5 6 
4. Your ability to breathe without shortness of breath? 1 2 3 4 5 6 
5. The amount of energy you have for everyday activities? 1 2 3 4 5 6 
6. Your ability to take care of yourself without help? 1 2 3 4 5 6 
7. The amount of control you have in your life? 1 2 3 4 5 6 
8. Your chances of living as long as you would like? 1 2 3 4 5 6 
9. Your family’s health? 1 2 3 4 5 6 
10. Your children? 1 2 3 4 5 6 
11. Your family’s happiness? 1 2 3 4 5 6 
12. Your sex life? 1 2 3 4 5 6 
13. Your spouse, lover, or partner? 1 2 3 4 5 6 
14. Your friends? 1 2 3 4 5 6 





16. The emotional support you get from people other than your 
family? 
1 2 3 4 5 6 
17. Your ability to take care of family responsibilities? 1 2 3 4 5 6 
18. How useful you are to others? 1 2 3 4 5 6 
19. The amount of worries in your life? 1 2 3 4 5 6 
20. Your neighborhood? 1 2 3 4 5 6 
21. Your home, apartment, or place where you live? 1 2 3 4 5 6 
22. Your job (if employed)? 1 2 3 4 5 6 
23. Not having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6 
24. Your education? 1 2 3 4 5 6 
25. How well you can take care of your financial needs? 1 2 3 4 5 6 
26. The things you do for fun? 1 2 3 4 5 6 
27. Your chances for a happy future? 1 2 3 4 5 6 
28. Your peace of mind? 1 2 3 4 5 6 
29. Your faith in a higher power? 1 2 3 4 5 6 
30. Your achievement of personal goals? 1 2 3 4 5 6 
31. Your happiness in general? 1 2 3 4 5 6 
32. Your life in general? 1 2 3 4 5 6 
33. Your personal appearance? 1 2 3 4 5 6 
34. Yourself in general? 1 2 3 4 5 6 
35. Your relief from coughing? 1 2 3 4 5 6 
36. The changes in your life that you have had to make because 
of your lung condition? 



















































































1. Your health? 1 2 3 4 5 6 
2. Your health care? 1 2 3 4 5 6 
3. Having no pain? 1 2 3 4 5 6 
4. Having no shortness of breath? 1 2 3 4 5 6 
5. Having enough energy for everyday activities? 1 2 3 4 5 6 
6. Taking care of yourself without help? 1 2 3 4 5 6 
7. Having control over your life? 1 2 3 4 5 6 
8. Living as long as you would like? 1 2 3 4 5 6 
9. Your family’s health? 1 2 3 4 5 6 
10. Your children? 1 2 3 4 5 6 
11. Your family’s happiness? 1 2 3 4 5 6 
12. Your sex life? 1 2 3 4 5 6 
13. Your spouse, lover, or partner? 1 2 3 4 5 6 
14. Your friends? 1 2 3 4 5 6 
15. The emotional support you get from your family? 1 2 3 4 5 6 
16. The emotional support you get from people other than your 
family? 
1 2 3 4 5 6 
17. Taking care of family responsibilities? 1 2 3 4 5 6 





19. Having no worries? 1 2 3 4 5 6 
20. Your neighborhood? 1 2 3 4 5 6 
21. Your home, apartment, or place where you live? 1 2 3 4 5 6 
22. Your job (if employed)? 1 2 3 4 5 6 
23. Not having a job (if unemployed, retired, or disabled)? 1 2 3 4 5 6 
24. Your education? 1 2 3 4 5 6 
25. Being able to take care of your financial needs? 1 2 3 4 5 6 
26. Doing things for fun? 1 2 3 4 5 6 
27. Having a happy future? 1 2 3 4 5 6 
28. Peace of mind? 1 2 3 4 5 6 
29. Your faith in a higher power? 1 2 3 4 5 6 
30. Achieving your personal goals? 1 2 3 4 5 6 
31. Your happiness in general? 1 2 3 4 5 6 
32. Your life in general? 1 2 3 4 5 6 
33. Your personal appearance? 1 2 3 4 5 6 
34. You to yourself? 1 2 3 4 5 6 
35. Being free from coughing? 1 2 3 4 5 6 
36. The changes in your life that you have had to make because 
of your lung condition? 
1 2 3 4 5 6 
 
Ferrans, C. E., & Powers, M. J. (1985). Quality of life index: development and psychometric properties. Advances in 












Appendix D  
Global Self-rating of Health 
(Adapted from Ware & Sherbourne, 1992)   
 
Instructions: Please respond to the question by marking one box in the row. 

























Appendix E  
Demographic Form 
Instructions: Answer questions as they relate to you. For most answers, check the box(es) most 
applicable to you or fill in the blanks. 
About You 
1. Your Age in Years, Today 





81 or more 
2. Your Gender  




3. Your Ethnicity 
(Select only one.) 
Hispanic or Latino 
Not Hispanic or Latino 
Unknown 
4. Your Race  
(Select only one.) 
American Indian/Alaskan Native 
Asian 
Black or African American 
Native Hawaiian or other Pacific Islander 
White 
More than one race 
5. Your Marital Status  
(Select only one.) 
Married  
Civil Union/Domestic Partnership 
Widowed 
Living with significant other 






6. Your Educational Background  
(Select only one.) 
 Less than high school 
Graduated high school or GED 
Some college or technical school 
Graduated college 
Postgraduate school or degree 
7. Your Employment Status  
(Select only one.) 
Currently working  
On leave of absence 
Retired (not due to ill health) 
Disabled and/or retired because of ill health 
Homemaker 
Unemployed 
8. Your Income Level  
(Select only one that reflects all sources of income earned in the past year.) 
Less than $10,000 
$10,000 to less than $20,000 
$20,000 to less than $35,000 
$35,000 to less than $50,000 
$50,000 to less than $75,000 
$75,000 to less than $100,000 
$100,000 or more 
I prefer not to answer this question. 
About Your Residence 
9. Who do you live with?  
(Select only one.) 
I live alone 
I live with family or friends 
10. Where do you live?  
(Select only one.) 
In a community of < 50,000 people 






About Your Breathing 
11. How long have you been diagnosed with COPD (Chronic Obstrcutive Pulmonary 
Disease, Emphysema, or Chronic Bronchitis)?  
(Select only one.) 
0-3 years 
3-10 years 
More than 10 years 
12. Are you a current or former smoker of cigarettes and/or pipes? 
(Select only one.) 
Yes 
No 
13. If  YES, what was or is the average number of cigarettes/pipes smoked per day? 
(Select only one.) 
_______ cigarettes 
_______ pipes 
14. If  YES, what was the total number of years as a smoker? 
______________ Years 
17. What is your current height and weight?  
 
____ feet   ____ inches  ____ pounds 
18. How many times have you visited your primary care provider due to breathing 
problems in the past 12 months? 
______ Times 
19. How many times have you visited am emergency department due to breathing problems 
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